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ABSTRACT 
 
The transmission of melamine from feed to poultry products 
 
Two studies were done to determine the distribution rate and efficiency of dietary melamine (MEL) to poultry 
meat and eggs.  The possibility of MEL distribution into meat and eggs after feeding cyromazine (CYR) was 
also investigated.  Five separate diets were formulated for broiler and layer chickens containing graded levels of 
MEL.  In the broiler trial (Experiment 1), a number of 480 day-old Cobb 500 broiler chickens were divided into 
five treatment groups.  Diets contained 0 (CON), 50 (MEL50), 100 (MEL100), 500 (MEL500) mg/kg MEL or 4 
mg/kg CYR (CYR4).  The duration of the trial was 36 days and breast muscle, kidney and liver samples were 
harvested on Days 11, 13, 15, 18, 22, 29 and 36 after the start of the feeding and analyzed for MEL.  For the 
duration of the trial, all experimental diets were presented ad libitum and feed intake, weight gain, mortality rate, 
feed conversion ratio (FCR), protein efficiency rate of birds and the European production efficiency rate were 
determined.  In the layer trial (Experiment 2), 120 Hyline Silver hens (24 weeks of age) were randomly divided 
into five treatment groups.  The treatment diets were the same as for Experiment 1.  The duration of the trial was 
20 days and layers received the treatment diets for the first 10 days after which the control diet was provided for 
another 10 days.  Feed intake, mortality rate, egg production and egg weights were recorded daily, while live 
weight was recorded at the beginning and end of the trial.  Dietary MEL levels of up to 500 mg/kg did not have 
any detrimental effect on production parameters for broilers.  In the layer trial, feed intake and egg weights were 
negatively affected by the MEL500 treatment.  Dietary MEL was absorbed by broilers and layers and rapidly 
distributed to the kidneys, livers, muscles and eggs.  As the dietary MEL concentration increased from 50 and 
100 mg/kg to 500 mg/kg, an increase (P < 0.01) was observed in muscle tissue and egg MEL residue 
concentrations.  Melamine concentration for broilers peaked at 22 days of age and decreased until day of 
slaughter.  The kidneys contained the highest MEL residue levels, compared to other organ tissues, such as 
muscle and liver.  In layer hens, a MEL distribution plateau in eggs was reached between Days 1 and 4 and 
decreased from Day 7 to 10.  The distribution of MEL in eggs was higher to albumin than to the yolk.  Upon 
withdrawal, MEL concentration in these tissues declined to undetectable levels within seven days.  No MEL 
could be detected in meat or eggs when birds received the CYR4 treatment.  The distribution efficiency (DEf) of 
MEL to meat and eggs did not appear to be dose dependant.  For meat, the DEf varied between 1.2 and 2.7% and 
for eggs it varied between 0.7 and 0.8%.  
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UITTREKSEL 
 
Die transmissie van melamien vanaf voer na pluimvee produkte 
 
Twee studies is uitgevoer om die verspreidings tempo en effektiwiteit van melamien (MEL) na hoender vleis en 
-eiers te bepaal.  Die moontlikheid van MEL verspreiding na vleis en eiers deur die voeding van cyromazien 
(CYR) is ook ondersoek.  Vyf aparte diëte is geformuleer vir braaikuikens en lê-henne wat verskillende MEL 
insluitings vlakke bevat het.  Vir die braaikuiken proef (Eksperiment 1), is 480 dag oud Cobb 500 braaikuikens 
ingedeel in vyf behandelings groepe.  Diëte het 0 (CON), 50 (MEL50), 100 (MEL100), 500 (MEL500) mg/kg 
MEL en 4 mg/kg CYR (CYR4) bevat.  Die tydsduur van hierdie proef was 36 dae en bors-, spier-, nier- en lewer 
monsters is ingesamel op Dae 11, 13, 15, 18, 22, 29 en 36 wat geëvalueer is vir MEL.  Tydens die verloop van 
die proef is alle eksperimentele diëte ad libitum gevoer en voerinname, massa toename, mortaliteit, 
voeromsettings verhouding, proteïen effektiwiteits tempo asook die Europese produksie effektiwiteits tempo is 
bepaal.  Vir die lê-hen proef (Eksperiment 2), is 120 Hyline Silver henne (24 weke oud) ewekansig verdeel in 
vyf behandelings groepe.  Die behandelings diëte het dieselfde MEL en CYR konsentrasies bevat as 
Eksperiment 1.  Die tydsduur van hierdie proef was altesaam 20 dae waarvan henne behandelings diëte vir die 
eerste 10 dae ontvang het, waarna henne vir die daarop volgende 10 dae ‘n kontrole dieët wat 0 mg/kg MEL 
bevat gevoer is.  Voerinname, mortaliteit, eier produksie en eier gewig is daagliks opgeteken, terwyl lewende 
massa aan die begin en einde van die proef gemeet is.  Melamien dieët vlakke tot 500 mg/kg het geen negatiewe 
effek op braaikuiken produksie parameters gehad nie.  Vir lê-henne, is slegs voerinname en eier gewig negatief 
beïnvloed vir MEL500.  Melamien is na inname geabsorbeer deur braaikuikens en lê-henne en het vinnig 
versprei na die niere, lewer, spiere en eiers.  Soos die MEL vlakke van die behandelings diëte toegeneem het van 
50 en 100 mg/kg na 500 mg/kg, het ‘n beduidende (P < 0.01) toename in spierweefsel en eier MEL residu 
konsentrasies voorgekom.  Melamien konsentrasies vir braaikuikens het gepiek op 22 dae en geleidelik 
afgeneem tot op dag 36.  In lê-henne het ‘n MEL verspreidings platu in eiers plaasgevind tussen Dag 1 en 4 en 
geleidelik afgeneem tydens Dag 7 en 10.  Die niere het die hoogste MEL residu vlakke bevat in vergelyking met 
die lewer- en spierweefsels.  Die verspreiding van MEL in eiers was hoër na die albumien as na die dooier.  
Tydens onttrekking het die MEL konsentrasie vlakke in hierdie weefsels in so ‘n mate afgeneem dat dit 
onbespeurbaar was binne sewe dae.  Geen MEL kon in vleis- en eiermonsters gemeet word vir CYR4 nie.  Die 
verspreidings doeltreffendheid (DEf) van MEL na vleis en eiers was nie dosis afhanklik nie.  Vir vleis het die 
DEf gevarieër tussen 1.2 en 2.7% en vir eiers tussen 0.7 en 0.8%.  
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Notes 
 
The language and style used in this thesis are in accordance with the requirements of the South African 
Journal of Animal Science. This thesis represents a compilation of manuscripts where each chapter is an 
individual entity and some repetition between chapters has been unavoidable.  
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1. CHAPTER 1   
2. General introduction 
 
Melamine (C3H6N6) is an industrial chemical utilised in a variety of industrial applications such as 
plastics, coatings, leather, paints, laminates, flame-retarding agent and table-tops among others (China 
Chemical Reporter, 2006).  In the feed industry the crude protein value for feedstuffs can be obtained 
by determining the nitrogen (N) value of the ingredient multiplied by 6.25 (Van der Merwe et al., 
1991).  The N level of pure melamine (MEL) is 667g/kg (Merck, 2001) which is equal to a crude 
protein level of 4168.75 g/kg.  This value is substantially higher than that of pure urea (2917 g/kg) 
which is renowned for its exceptional high N content.  Melamine production increased considerably 
during the early 2000’s in China and in 2006 MEL production was reported to be in excessive surplus 
(China Chemical Reporter, 2006), with an estimated worldwide production of 1.2 million tons for 2007 
(Bizzari et al., 2008).  Generally, MEL and its derivates are not present in human foods or animal 
feeds; however, due to the situation described above, the inclusion of MEL as a fraudulent protein in 
feed seemed to be an alluring substitute for the more costly protein supplements and at the same time 
would result in decreasing the severe surplus.  
  
The first serious concerns regarding the inclusion of MEL in food became evident in the 2006/2007 pet 
food scandal.  More than 1000 dogs and cats died in various countries due to renal failure caused by 
accumulated kidney stones (WHO, 2008).  This resulted in 1154 recalls of assorted pet foods, while the 
main contaminant was promptly identified as MEL tainted corn gluten 60.  The second appalling MEL 
scandal emerged in 2008 after it became known that six babies died and 294 000 became ill after 
drinking MEL-tainted infant formula (WHO, 2008).  More than 50 000 of the infants were reported to 
be hospitalized with dysfunctional urinary symptoms caused by renal tube blockages and kidney stones 
(WHO, 2008).  More than 22 Chinese companies have sold MEL contaminated milk.  These practices 
were restricted by the Chinese government in an attempt to reduce MEL adulteration. 
 
Various different food sources and certain environmental practices expose humans to MEL and its 
analogues.  The occurrence of MEL exposure may possibly also be due to the use of triazine based 
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pesticides (for instance cyromazine) used to control fly populations in cattle and poultry manure 
(Sancho et al., 2005).  When cyromazine (CYR) is dealkylized, one of the degradated products is MEL 
(Sancho et al., 2005), motivating the relevance of investigating the detection of MEL metabolized from 
CYR in poultry meat and eggs which is reported in this thesis.  Cyromazine is also used on field crops 
or sprayed onto fruits and vegetables.  Patakioutas et al. (2007) detected MEL residues of less than 1 
mg/kg on the edible parts of crops (tomato, lettuce and celery), after applying CYR.  Melamine is also 
used as N source for slow release urea-based fertilizers and may be a major MEL contaminant in food 
and water (Hilts et al., 2008).  The work by Mosdell et al. (1987) supports the latter by showing that 
plants had taken up N in significant amounts, following the application of a MEL-urea combination.  
Further reports (OECD, 1998) stated that MEL was detected in fish and river water in Japan; however, 
the data were considered insufficient to determine MEL pollution in general in Japanese river fish 
populations and drinking-water.  Other examples of human exposure to MEL exist, for instance 
migration of MEL through food packaging material into food (Lu et al., 2009).  
 
In the poultry feed industry of South Africa, MEL was present as an adulterant in maize gluten 60, a 
raw material commonly used in the industry.  Chinese soya products imported to Europe and France 
during 2008 also tested positive for MEL and were included in poultry rations.  Contaminated fishmeal 
was also exported to Canada (CBC News, 2007) and tainted wheat gluten and rice protein to the US 
(Weise et al., 2007).  All the identified contaminated feeds have been recalled.  Cyromazine, the active 
ingredient of Larvadex® which is included in laying-hen diets to control flies, may be metabolized to 
MEL in the animal, resulting in the possibility of MEL being detected in the meat or eggs.  A residual 
maximum of 50 ng/g for CYR in the edible parts of eggs and poultry meat are allowed as stipulated by 
the US Code of Federal Regulations (1987); however, residual levels in consumer products and CYR 
inclusion levels in animal diets differ between countries depending on their application as a veterinary 
drug. 
 
There were approximately 94.7 million tons of poultry meat (U.S. Department of Agriculture, 2009) 
and 60.678 million tons of eggs produced worldwide during 2009 (FAOSTAT, 2010).  From these 
facts it is evident that massive economical losses could be experienced when tainted poultry products 
have to be destroyed due to products containing MEL residues that exceed legal baseline levels.  The 
general position of animal nutritionists and veterinarians are to not rely on so-called safe inclusion 
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levels, but that feed should rather contain undetectable levels of MEL.  It has been accepted, however, 
that the presence of MEL in the environment is inevitable and may contribute to a background level of 
contamination in feeds (WHO, 2008).  Therefore, restrictions on maximum MEL inclusion levels in 
various feedstuffs have been set as an alternative resort.  The World Health Organisation (WHO) has 
set the tolerable daily intake (TDI) levels for humans at 0.2 mg/kg body weight (Setiogi, 2008), and the 
maximum allowable MEL concentration of human foods at 2.5 mg/kg, while the maximum allowable 
level for infant formula was set at 1 mg/kg.  For animal feeds, the industry has also accepted 2.5 mg/kg 
MEL as the maximum allowable MEL level.  However, products containing excessive MEL residues 
could still surface in countries with no restriction policies.  To justify the current study, the latter could 
be prevented by implementing scientific recommendations based on experimental findings revealing 
the maximum inclusion of MEL in feed that would result in MEL contaminated animal products that 
are within the 2.5 mg/kg restriction limit.  From a different perspective, if accidental feeding of MEL 
contaminated feed occurred, a minimum withdrawal time can be applied as guideline before animal 
products are considered as safe to harvest for human consumption. However, little scientific data exists 
that indicate what this minimum withdrawal period should be. 
 
Therefore the current study had the following aims: 
1. To determine the distribution rate of three different levels of MEL in poultry meat and eggs.  
2. To determine the withdrawal rate of MEL from meat and eggs after terminating MEL exposure 
in the diet. 
3. To determine the efficiency rate at which MEL could be distributed into meat and eggs. 
4. To determine the possibility of MEL distribution to meat and eggs after feeding CYR. 
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CHAPTER 2                                                                             
Literature review 
 
2.1. Introduction 
 
The international agricultural sector is under constant pressure to satisfy the world’s infinite demand 
for dietary resources.  Firstly, arable agricultural land is decreasing annually due to the increase in 
residential areas to support the fast growing world population.  New agricultural land can be cultivated, 
but at a considerable cost and feasible expansions are limited.  Secondly, rapidly increasing input costs 
during the past few years have added increased pressure on raw material prices.  In South Africa, the 
price of fertilizer has more than doubled during the past three years (FSSA-MVSA, 2010), straining 
marginal profits severely, forcing higher purchase prices for the feed sector, not even mentioning the 
impact of the fluctuating oil prices (Digital Look, 2010) or the effect of the past recession.  These 
difficulties leave the feed industry with no other choice than to explore cheaper and more effective 
alternatives for high dietary protein products. 
 
It is a well-known fact in the agricultural industry that feedstuffs containing high protein levels are 
classified as one of the most expensive raw material groups (McDonald et al., 2002).  One of these 
categorical ingredients is fish meal which is considered to be an excellent protein source for 
monogastric feeding; however, the protein contents and its digestibility may vary in quality due to 
different processing practises and the type of fish products that have been used as fish meal ingredients 
(McDonald et al., 2002).  This varying quality is directly linked to the price and it is therefore tricky to 
formulate least cost rations containing fish meal.  Urea contains 466g/kg N (McDonald et al., 2002); 
however, it is mainly used in ruminant rations and was therefore not applicable for the current research 
study.  Therefore, when comparing melamine (MEL) to fishmeal, it is evident that fishmeal is per 
weight more expensive to add as a high N feedstuff to the diet than MEL, concluding the more 
appealing use for MEL.   
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Melamine is not an effective source of non-protein N for ruminants due to the slow and incomplete 
hydrolysis of MEL (Newton & Utley, 1978).  Furthermore, in a rat study by Mast et al. (1983) it has 
been shown that more than 90% of ingested MEL was excreted within 24 hours, which further 
accentuated the insignificant nutritional contribution of MEL.  Despite the theoretical desirable 
qualities that MEL displays, the discovery of alternative feed additives should rather be explored on 
other biological fields, such as entomology.  Melamine has not been permitted to be used as a direct 
feed additive; however, traces may be detected in feed due to crops fertilized with MEL related 
products, or as a breakdown product from cyromazine (CYR) that has been included as a veterinary 
drug.  Gossner et al. (2009) reported that the levels of MEL in contaminated animal feeds, ranged from 
3.3 mg/kg to 21 000 mg/kg during 2008 and 2009.  These practices are currently considered as 
unethical and should not be tolerated by authorities while the public should be properly informed of the 
current situation and possible ill symptoms. 
 
The following review and in depth discussion will reveal the chemical nature of MEL and CYR and 
their application.  Also, the relationship between MEL and cyanuric acid will be mentioned since these 
two substances are linked to each other throughout the literature (Brown, 2007; Caldas, 2007; Hilts et 
al., 2008; Reimschuessel et al., 2008; WHO, 2008; Hau et al., 2009; Sebastian, 2009; Kobayashi et al., 
2010 and WHO, 2010).  The metabolism and toxicological effects of MEL and CYR will be discussed, 
followed by the distribution characteristics of these two substances in poultry meat and eggs, as well as 
in products of other species.   
 
2.2. Chemistry and application of melamine 
 
Melamine (1,3,5-triazine-2,4,6-triamine) with chemical formula C3H6N6, is an organic compound and a 
trimer of cyanamide.  Melamine is commonly found as a white solid and has a molar mass of 126.12 
g/mL, a small molecule with high nitrogen content (Osborne et al., 2008).  It is used in the manufacture 
and processing of a variety products ranging from plastics, coatings, leather, paints, laminates, flame-
retarding agent and table-tops and in recent years it has been added to certain food products.  Some 
bacteria have the ability to metabolize MEL; however, the same is apparently not true for mammals 
and therefore it holds no nutritional value for animals (Osborne et al., 2008). 
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Figure 1  The chemical process in the formation of MEL related compounds (Tyan et al., 2009). 
 
Cook et al. (1981) stated that MEL is biodegradable as illustrated in Figure 1 and Jutzi et al. (1982) 
confirmed the derivative pathway of MEL with four different methods.  Melamine is commercially 
synthesized from urea (Hau et al., 2009) and the by-products ammeline, ammelide and cyanuric acid 
originate during hydrolysis (Figure 1).  The melting point of MEL is 345°C, which explain why some 
plastic ware melts after high heat exposure (Tyan et al., 2009).  Melamine is not very soluble in water 
(3 240 mg/L at 20°C) and according to Chapman et al. (1943) less than 1% MEL is required to saturate 
an aqueous solution after being diluted in water at 20°C.  This feature as discussed later in this study is 
the single most important aspect attributing to renal complications.  
 
2.3. Chemistry and application of cyromazine 
 
Cyromazine (N-Cyclopropyl-1,3,5-triazine-2,4,6-triamine) is a triazine with a crystalline appearance.  
The molecular formula of this substance is C6H10N6 and it has a molar mass of 116.19 g/mol (Merck, 
2001).  Cyromazine is a cyclopropyl that is a MEL derivate (Figure 2) and alternative names include 
Larvadex®, Trigard®, Vetrazin® and CGA-72662 (Merck, 2001).   
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Figure 2  The chemical structure of Cyromazine (Merck, 2001). 
 
The distinctive utility of CYR is to alter the formation of the chitin layer of fly larvae that would hatch 
in poultry manure.  It has been postulated that CYR interferes with the hormone ecdysone, which 
regulates ecdysis and cuticle deposition in insects (Pfeifer, 1993).  Typically it is added to layer feed 
(marketed under the Larvadex label), when flies start to negatively affect bird comfort over time.   The 
ingested CYR will then pass the digestive system into the faeces, exposing larvae to the product 
without any additional labour.  Conventional methods involved a technique where manure was sprayed 
with a similar product by hand, which is considered to be more labour intensive than the addition of 
CYR as feed additive.  Reasons for concern in the application of CYR as feed additive arose after it 
was hypothesized that the ingested CYR could be metabolized by the birds to MEL, which might be 
deposited in eggs and body tissue intended for human consumption.  This hypothesis will be tested in 
the current study and compared to findings of other authors. 
 
2.4. The relationship between melamine and cyanuric acid 
 
The application of the aims as stipulated under the general introduction is to provide the poultry 
industry with information concerning the distribution rate of MEL and CYR in meat and eggs.  Even 
though the toxic effects of cyanuric acid (CYAN) will not be evaluated in the current study, it is still 
inevitable to mention the interaction of this compound with MEL and how it is related to 
nephrotoxicity in combination with MEL.  Cyanuric acid (s-triazine-2,4,6-triol) is a white solid that is 
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structurally related to MEL (Figure 1) and is generally used as a water stabilizer to minimize 
hypochlorous acid decomposition in swimming pools after exposure to sunlight (Downes et al., 1984).  
According to Puschner et al. (2007), intake of MEL and CYAN alone seems to be less of a problem 
than ingesting a combination of the two chemicals (MEL-cyanurate) which has repeatedly been 
reported to induce kidney disorders.  Similar to MEL, CYAN has a low solubility in water (2 000 mg/L 
at 25°C) and the simultaneous addition of the two substances result in an isomeric interaction, creating 
an insoluble (2 mg/L) crystalline structure (Plate 1) in the distal nephrons (Hau et al., 2009).  The 
motive for the inclusion of CYAN in animal feed remains uncertain.  It is speculated that CYAN has 
been added as an adulterant similar to MEL in feed due to its high nitrogen content.  Another theory is 
that bacterial MEL metabolism could have occurred in the toxic pet food, creating CYAN as a by-
product (Osborne et al., 2008).    
 
 
 
Plate 1  MEL crystals on the left, CYAN crystals in the middle and the pin like crystals of MEL-
cyanurate on the right (Kobayashi et al., 2010). 
 
2.5. The metabolism and distribution of melamine and cyanuric acid 
 
Very little is presently known about the exact mechanism of MEL metabolism and nephrotoxicity; 
however, it appears as if MEL is quickly metabolized by the body.  Allen et al. (1982) reported that 
humans excreted 98% of ingested CYAN within 24 hours in urine.  Approximately 90% of all ingested 
MEL in a rat study was excreted in the urine within 24 hours (Mast et al., 1983).  Melamine primarily 
causes severe damage to the kidneys which ultimately may result in death if the animal receives excess 
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levels of MEL.  These levels vary between different species and will be discussed in more detail later.  
It is said that the mechanism of kidney failure observed in animals due to MEL ingestion can be 
compared to uric acid nephropathy that occur in humans because both induce mechanical obstructions 
which is similar to humans enduring gout (Reimshuessel et al., 2008).  Therefore, renal failure due to 
MEL toxicity is the result of intrarenal crystal obstruction causing increased renal pressure which 
reduces renal blood flow (Reimshuessel et al., 2008). 
 
Approximately 22-25% of the blood flow generated by cardiac output in a human body enters the two 
kidneys (Sebastian, 2009).  Toxins are removed by the kidney via glomerular filtration, tubular 
excretion through passive diffusion and active tubular secretion (Sebastian, 2009).  Sebastian (2009) 
explains that the most common site for toxin related injury is in the proximal convoluted tubule.  
Reasons for this is that some toxins are activated by enzymes (cytochrome P450 and cysteine conjugate 
β-lyase) localized in the epithelial cells of the proximal tubular.  Also the epithelium cells of the 
proximal tubules are more loosely arranged than the distal tubular cells, making toxin intrusion 
effortless.  The proximal convoluted tubular epithelial cells seem to be most susceptible to injuries 
related to decreased blood flow due to obstruction of the tubule.  When feeding high levels of MEL or 
CYAN alone, stone formation occurs mainly in the proximal tubules (Kobayashi et al., 2010).  
Interestingly, histopathological evaluations showed complications in the distal tubule as well as in the 
collection ducts caused by MEL-cyanurate crystals (Dobson et al., 2008; Kobayashi et al. 2010).  A 
theory which is currently globally accepted has been developed to explain these findings.  It states that 
the glomerular filtrate has a pH of 7.4 after which it decreases to approximately 6.8 in the proximal 
tubules due to H+ secretion and further H+ secretion in the collecting ducts via luminal proton ATPases 
can decrease the urinary fluid pH to under 6 (Barac-Nieto, 2004).  Bhalla et al. (2009) reported that 
MEL-cyanurate stone formation occurs at pH 5.8 which may be the reason for stone formation in the 
distal tubules and therefore low urinary pH may be encouraging crystal formation and ultimately 
causing acute renal failure. 
 
Infants and very small children seem to be more severely affected by MEL than adults due to several 
reasons including that infants have to take in more feed according to their body weight compared to 
adults; more frequent feedings; differences in intestinal absorption and immature kidney functioning.  
However, the main reason why infants are more susceptible is that their blood serum and urine contain 
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considerably higher levels of uric acid compared to adults and older children, increasing the possibility 
for uric acid-MEL precipitation in the renal tubules.  Also it is said that infants have lower solutes 
(citrate and phosphate) to compete against MEL for binding sites, making susceptibility even more 
severe (WHO, 2010).  In theory these findings might also apply to the avian species due to their higher 
uric acid blood serum levels compared to mammals.  Layer chickens have lower uric acid levels than 
non-layer birds and uric acid serum levels decrease with age in most species while low protein diets are 
also thought to initiate low uric acid levels (Bowes et al., 1989). 
 
The lowest daily intake of MEL that would initiate bladder stone development was reported by 
Melnick et al. (1984) to be 750 mg/kg for rodents after ingesting MEL for 13 weeks.  Renal stones 
collected from patients who ingested MEL alone are primarily composed of MEL and uric acid.  These 
two substances are bonded at a 1:1 ratio in rats and for humans more or less 1:2 due to the higher uric 
acid levels in humans (Reimshuessel et al., 2008).  To identify the origin of the crystals, they are 
stained with Oil Red O.  Crystals composed of calcium phosphate and calcium oxalate did not stain 
with this reagent; however, MEL-containing crystals will stain with Oil Red O and therefore they are 
different from the typical calcium stones (Sebastian, 2009).  Unlike calcium oxalate crystals, MEL-
cyanurate crystals cause renal failure due to stone obstruction in the renal tubules (Kobayashi et al., 
2010).  Calcium oxalate crystals on the other hand will begin to stick to tubular epithelial cells and will 
grow by expressing stone matrix proteins (Tawada et al., 1999). 
 
Dobson et al. (2008) reported increased kidney weights in rats receiving MEL-cyanurate (3.61 g) 
compared to the control group (2.05 g).  A triazine mixture containing MEL (400 mg/kg), ammeline, 
ammelide and cyanuric acid (40 mg/kg each) also increased kidney weight (2.62 g).  Furthermore urea 
N levels in blood were substantially higher than normal blood and creatinine clearance was also lower 
with low urine pH recordings for both MEL mixtures.  These findings are all an indication of renal 
dysfunction.  Since it has been established that the binding sites of the MEL-cyanurate molecules are 
dependent on hydrogen bonding of corresponding amino and hydroxyl group of triazines, Dobson et al. 
(2008) explains that ammelide might substitute CYAN in the lattice if an excess of MEL is present 
which might explain the increased kidney weight of the mixed triazine group.  The author predicted 
that ammeline could substitute MEL if CYAN is in surplus. 
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An operating model was subsequently developed to illustrate the toxicity of MEL-cyanurate:  MEL-
cyanurate was confirmed to remain stable in gluten feed and during the manufacturing of processed pet 
food after examining samples by infrared spectroscopy.  After ingestion the complex was dissociated in 
the gastric lumen due to the low pH content.  From this stage on Dobson et al. (2008) suspected that 
due to the different pKa values of MEL (5) and CYAN (6.9) the acid is absorbed by the stomach and 
the base in the small intestine or else the two compounds would re-establish the crystal structure.  Both 
compounds were found in the renal filtrate allowed the opportunity to restructure an insoluble complex 
creating a physical blockage.  The author could not explain why the substances did not restructure until 
reaching the tubules; however, two theories were proposed:  The two substances only recombined after 
reaching a certain concentration point, which might occur as the compounds progress through the 
osmotic gradient of the kidney.  Alternatively, it might be that MEL and CYAN interfere with the 
metabolism of uric acid and possibly precipitate in the tubules.  The presence of ammelide, ammeline 
and CYAN increases circulating uric acid by inhibiting hepatic uric acid oxidase (Dobson et al., 2008).  
They also postulated that the compounds compete for a renal acid transporter; however, this remains to 
be proved.  No cellular damage to the tubular epithelia cells were noted before the crystals were 
formed. 
 
It is worth mentioning the fascinating work conducted by Buur et al. (2008) on developing a 
physiologically based pharmacokinetic model to predict the residual MEL levels in kidney and liver 
tissues of rats and pigs.  The pig model was further applied to estimate withdrawal times after they 
were accidentally fed with contaminated feed.  A similar study has been reported by Baynes et al. 
(2010) in goats.  Due to different retention times, glomerular filtration rate and other pharmacokinetical 
differences between ruminants and monogastric animals, further research is required to refine the 
accuracy of these predictions to complete these studies.   
 
2.6. The metabolism and distribution of cyromazine 
 
As mentioned, CYR is a derivate of MEL and therefore it was thought that CYR is metabolized 
similarly to MEL in the body.  Similar to MEL, CYR is also rapidly excreted by rats, mainly in urine 
within 24 hours and 95% of all ingested CYR is excreted within 72 hours (Simoneaux et al., 1978).  
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Only approximately 3% of the excreted CYR was presented in the faeces. Pfeifer (1993) showed that 
CYR could not be hydrolyzed in vitro at pH 5, 7 or 9 at different temperatures (50°C and 70°C) unless 
under strong acidic conditions.  The main pathway of degradation appeared to be by means of 
photolysis; however, other researchers’ reported contradictory results.  When CYR was diluted in an 
aqueous solution, photo-degradation to MEL only occurred after the addition of acetone.  Therefore, 
the conclusion could be made that very little CYR could be metabolized to MEL in the body and that 
any complications reported due to dietary CYR inclusions are supposedly due to CYR and not to MEL 
metabolized from CYR.  
 
Cyromazine is almost completely absorbed after ingestion and distributed to all organs and body 
tissues (Caldas, 2007).  Brake et al. (1984) showed evidence of liver abnormalities in broiler breeders 
fed 1000 mg/kg, thereby implying damage to the metabolic system.  Wilson et al. (1983) recovered 
fatty livers from their treatment necropsy tests; however, it could not be associated with any of the 
treatments.  Renal injury has been suggested by Brake et al. (1989) after wet litter were recorded for 
turkeys receiving CYR levels of 1000 mg/kg and more.  It was proposed that the kidneys eliminate 
CYR and related substances from the body and have a metabolizable threshold after which the renal 
system will not be able to manage toxin elimination sufficiently.  From the study by Capps (1990) on 
rodents, the primary emission route is through renal excretion where 52-78% of the ingested CYR were 
excreted within 24 hours, which is contradictory to the 97% reported by Caldas (2007).  The reports of 
the two researchers, however, agreed that the excreted components were 72% unchanged CYR, 9% 
hydroxyl-CYR, 7% MEL and 2% 1-methyl-CYR.  According to Keiding (1999) 2-14% of ingested 
CYR was metabolized to MEL.  In the study reported by Caldas (2007), laying hens received a diet 
containing 5 mg/kg CYR for seven days.  Almost all of the residuals were recovered (99.8%) of which 
the excreta contained the highest residual level (99.1%) followed by egg albumin (0.4%), yolk (0.2%), 
tissue (0.1%) and expired CO2 (0.1%).  The birds were euthanized and average CYR distribution levels 
measured for body tissue were the highest for liver (0.31%) whilst renal tissue and breast muscle were 
0.019% and 0.010% respectively.  Supposing that 7% of the deposited CYR is metabolized to MEL 
(Caldas, 2007), the calculation could be based on the findings above that 0.00133 mg/kg MEL was 
potentially deposited in the renal tissue and 0.0007 mg/kg in breast muscle tissue for the study of 
Caldas (2007) due to CYR ingestion.  
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2.7. Toxicity and production impact of melamine and melamine-cyanurate 
 
Melamine and MEL-cyanurate most commonly cause renal complications and the degree and 
prolonged presence of toxicity can be classified as acute or chronic.  One of the most evident MEL 
toxicity studies was performed by Clark et al. (1966) on sheep long before the Chinese scandal 
surfaced.  Sheep fed MEL contaminated feed containing more than 25 g a day all died of acute toxicity.  
Loss of appetite and crystals in the kidney tubules accompanied by nephrosis and haemorrhagic cystitis 
were observed.  High blood urea nitrogen levels were recorded pre mortem.  Broiler mortalities showed 
enlarged pale kidneys after being exposed to 1500-3000 mg/kg MEL and opaque bile was observed in 
the gallbladders (Ledoux et al., 2009).  Crystals and lesions were found in the renal tubules and were 
similar to those found in cats, identifying MEL as the major cause for renal failure (Ledoux et al., 
2009). 
 
After chronic exposure to MEL, increased urinary output were noted in dogs with aggressive stone 
formation (Tusing, 1953).  The latter appears to be the only concurrent sign for chronic toxicity.  
Melnick et al. (1984) observed that chronic kidney failure occurred after feeding rats 150 mg/kg MEL 
for 90 days.  Urinary bladder stones were formed and later this probably led to bladder tumours.  
Bhalla et al. (2009) reported inflammation and necrosis of the distal tubular cells and larger stones in 
the tubules and papilla after chronic exposure for only MEL.  Hau et al. (2009) stated that the toxicity 
of MEL alone is low and that the 50% lethal dose (LD50) is 3161 mg/kg body weight for rats.  However 
the researcher also mentioned that high levels of MEL will cause the formation of urinary stones and 
acute renal failure.  No adverse effect on renal function was found after feeding rats 240 mg/kg MEL 
for 14 days (Kobayashi et al., 2010).  Additional reports mentioned that MEL affected the dogs’ 
digestive tract after intake while nausea, vomiting and diarrhoea were some of the observed symptoms 
(Jeong et al., 2006).  Stone formation was more severe in smaller animals and animals with low fluid 
intake and higher MEL intake.  Males were more affected than females due to their increased risk for 
stone formation (Hau et al., 2009).  No explanation for increased stone formation in males was 
provided by the author; however, it was reported that male serum has higher uric acid levels than 
females and as explain previously MEL interacts with uric acid and precipitates in the renal tubules 
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(Bowes, et al., 1989).  Therefore animals with higher uric acid levels tend to be more susceptible for 
MEL-uric acid stone formation.   
 
Some bladder epithelial changes (due to bladder calculi) were reported by Hammond et al. (1986) after 
feeding levels of up to 2200 mg/kg sodium cyanurate to rats with no other occurring defects.  Low 
toxicity of CYAN (LD50 of 7700 mg/kg body weight for rats) was reported by the World Health 
Organization (2008).  Cyanuric acid crystals developed in the renal tubules and were reported to cause 
renal tissue damage such as tubular dilatation necrosis and fibrosis.  No adverse effects were observed 
in rats at levels below 150 mg/kg.  
  
Studies on the simultaneous ingestion of MEL (0.2%) and CYAN (0.2%) in cats resulted in acute renal 
failure within 48 hours after feeding (Osborne et al., 2008).  Severe renal interstitial oedema and 
haemorrhage were reported and crystals were found in the distal nephrons accompanied by tubular 
epithelial necrosis.  One of the first adverse effects to occur in the nephron during acute renal failure is 
a drop in the glomerular filtration rate, causing excess urea and non-protein nitrogen substances to 
accumulate in the blood, termed azotaemia.  Azotaemia and hyperphosphatemia were also reported in 
acute cases by Sebastian (2009).  The insoluble crystals had a green colour and were composed of 70% 
CYAN and 30% MEL.  In the study of Kobayashi et al. (2010) an administered MEL-cyanurate dose 
of only 12 mg/kg/day resulted in crystal formation in the renal tubules.  Chronic symptoms on the other 
hand showed inflammation and fibrosis with larger crystals in the distal nephrons.  Similar 
observations were made in fish and pigs (Reimschuessel et al., 2008).  
 
Increased fluid intake seemed to reduce the incidence of stone formation and higher salt inclusion 
levels in the diet stimulated water intake which also helps to reduce the formation of stones 
(Ogasawara et al., 1995).  The preliminary treatment procedures according to the Chinese Ministry of 
Health (2008) are to increase daily water intake and to add urinary alkalizes as a food supplement.  
Pain management and surgical treatment could be required if all else fails.  
 
Many adverse production parameters were observed when feeding MEL diets of 1500 mg/kg and more 
to broilers over a 14 day period (Ledoux et al., 2009).  Feed intake decreased after exceeding 1000 
mg/kg and the average daily gain decreased for all groups receiving more than 1500 mg/kg which 
18 
 
became more prominent as the dose increased, especially beyond 2000 mg/kg.  Interestingly enough 
the FCR also decreased significantly (P< 0.001) for the 2500 and 3000 mg/kg groups compared to all 
the other treatments, which indicated that the decrease in weight gain was not affected as severely as 
the feed intake.  The first mortalities were already recorded from day five and mortality rates of more 
than 12% were observed after 2000 mg/kg and increased up to 30% for the 3000 mg/kg group.  Bai et 
al. (2010) provided MEL feed (0, 100, 250, 500, 1000 and 2000 mg/kg) to layers for 34 day and 
observed no difference between treatment levels regarding egg production, mortality and body weight.   
After feeding layer ducks different MEL inclusion diets (0, 1, 5, 25, 50 and 100 mg/kg), no differences 
in egg weight, egg production, feed intake or feed conversion was reported (Yuchang et al., 2010); 
however, these results could be expected due to the low inclusion levels 
 
2.8. Toxicity and production impact of cyromazine 
 
After following a detailed search, very little relevant literature reported clinical CYR toxicity 
symptoms.  The LD50 for rats after ingesting CYR was reported to be between 3387-5033 mg/kg (Bathe 
et al., 1978; Sabol, 1987; Pheifer, 1993).  The overwhelming adverse effect of CYR when chronically 
administering an oral dose of 1000 mg/kg and more was weight loss due to decreased feed intake and 
recovery was quickly established after withdrawal of CYR in rats (Bathe et al., 1978; Goldenthal et al., 
1979; Sabol, 1987; Pheifer, 1993) and dogs receiving more than 3000 mg/kg (Jessup et al., 1979).  
Decreased liver weights were reported for rats receiving more than 1000 mg/kg CYR (Goldenthal et 
al., 1979) and some reproductive complications became evident in rats receiving the same dose (Blair 
et al., 1981).  Pheifer (1993) mentioned that CYR can be considered to have a low acute toxicity level.  
Even though prominent weight loss were reported for many species receiving more than 1000 mg/kg 
the NOAEL (no-observed-adverse-effect level) was established at 300 mg/kg. 
 
From the available literature it appears as if broiler breeders are more sensitive to CYR than layers and 
turkeys (Brake et al., 1984; Brake et al., 1985; Brake et al., 1989).  In the study of Brake et al. (1983) 
layers at 27 weeks of age received 3000 mg/kg CYR, but it had to be reduced to 1000 mg/kg due to an 
elevated mortality rate.  These findings were similar to the response observed by Brake et al. (1984) 
where initial doses of 3000 mg/kg fed to broiler breeders were reduced to 2000 mg/kg and further 
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reduction to 1000 mg/kg was implemented after prolonged high mortality.  The authors unfortunately 
did not report a mortality rate or an indication of the LD50. Levels above 1000 mg/kg reduced 
reproductive and progeny performance with high mortalities, body weight loss and poor feed 
conversion ratios (FCR).  Decreased fertility, hatchability and egg production were also reported.  
Cyromazine was reported to be non-toxic to young layers when ingesting 10 000 mg/kg/day CYR for 
four weeks and 1000 mg/kg for 20 weeks (Brake et al., 1985); however, severe weight loss was 
recorded for both dosage levels.  According to the findings of Brake et al. (1989) administered levels 
of 2000 mg/kg CYR or less are non-toxic to turkeys; however, a marked decrease in feed intake and 
growth were observed in turkeys receiving levels between 500-2000 mg/kg CYR.  Despite the 
occurrence of suppressed body weights and poor reproductive performance, these production traits 
were reversible after CYR was withdrawn from the diets of broiler breeders (Brake et al., 1984), layers 
(Brake et al., 1985) and turkeys (Brake et al., 1989). 
 
It is interesting to note that CYR inclusion of 300 mg/kg in layer diets resulted in increased egg 
production compared to 0 mg/kg and 30 mg/kg over a period of 32 weeks; however, a decline in egg 
weight was reported for week 32 where shell weight was significantly decreased compared to the 0 
mg/kg treatment (Brake et al., 1983).  For turkeys however no significant difference in egg production 
(P > 0.05) were found after feeding different levels of up to 2000 mg/kg, emphasising the hardiness of 
turkeys compared to broiler breeders against CYR.  Inclusions of 1000 mg/kg in layer and broiler 
breeder diets had adverse effects on egg production and egg weight, but broiler breeders revealed an 
excellent feed conversion ratio (FCR) compared to the 0 mg/kg group.  The birds reduced their intake 
in an attempt to decrease CYR intake and Brake et al. (1985) concluded that a diet containing CYR 
reduced food wastage or possibly improved nutrient utilization and therefore the enhanced FCR.  
Decreased shell weights after chronic exposure to 1000 mg/kg CYR were measured; however, no 
significant (P > 0.05) fertility or hatchability difficulties were observed.  Inclusion levels of 300 mg/kg 
or less had no deleterious effects on reproductive and progeny performance (Brake et al., 1984; Brake 
et al., 1985; Buhr et al., 1983; Cecil et al., 1981).  Some residual effects were visible in the progeny 
and lower body weights were reported for the 1000 mg/kg treatments.  The poorer performance for the 
1000 mg/kg group could be explained by the decrease in egg weight; however, the 300 mg/kg 
treatment also had decreased egg weights but chick weight was not negatively affected compared to the 
0 mg/kg and 30 mg/kg group with the highest egg weights.  According to Brake et al. (1984), 
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metabolic damage is caused by CYR ingestion and therefore nutrient deposition could be retarded in 
the egg, explaining the decrease in chick body weight without inhibiting liveability. 
 
Contradictory results were reported by Wilson et al. (1983) where layer breeder hens who received 
1000 mg/kg CYR had the highest egg production rate compared to 0, 50, 100 and 500 mg/kg with no 
suppressed feed intake and zero mortality.  Egg production was however reduced significantly (P < 
0.05) at 2000 mg/kg which corresponds to similar research (Brake et al., 1983 and Brake et al., 1985).    
However, in a second experiment for the same study the treatment that received 1000 mg/kg CYR did 
not differ from the other treatments regarding egg production and was indeed the lowest of all the 
treatments with the highest mortality rate.  Even though no toxic effects can be identified after 
ingesting CYR, the US EPA (1999) prescribes that the inclusion of CYR may not exceed 5 mg/kg in 
poultry feed and that a 72 hours withdrawal period must be allowed before slaughter. 
 
2.9. Melamine distribution and withdrawal in animal products 
2.9.1. Poultry meat and eggs 
 
According to Thompson et al. (2008), MEL and its compounds are rapidly eliminated by the kidneys 
and do not accumulate in the body.  A comparison between the findings of different researchers 
regarding MEL distribution and withdrawal rates in eggs is displayed in Table 1 in an attempt to obtain 
an objective idea of the current study field.  The values reported by MAFF (2010) as stipulated in 
Table 1 revealed a plateau on day 12.  
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Table 1  Comparison between maximum melamine distribution (mg/kg) and melamine residuals in 
eggs after withdrawal from the feed. 
    Inclusion level (mg/kg) 
¹Day Author   2 5 30 50 60 100 250 500 1000 2000 
Distribution 
  Bai et al. (2010) - - - - - 1.6 3.0 6.7 11.7 28.7 
  Chen et al. (2010) - 0.3 - 1.0 - 1.9 - - - - 
  MAFF (2010) - - 0.7 - 1.6 - - - - - 
  Yuchang et al. (2010) 0.1 - - - - 2.4 - - - - 
Withdrawal 
10   Bai et al. (2010) - - - - - ND ND ND ND ND 
7   MAFF (2010)   - - ND - 0.04 - - - - - 
¹Days after MEL exposure has been discontinued. 
 
From Table 1 it is evident that there exists an upward trend for MEL distribution as the administered 
dose increases and that a negligible amount of MEL is present after a seven day withdrawal period.  
Bai et al. (2010) provided MEL feed (0, 100, 250, 500, 1000 and 2000 mg/kg) to layers for 34 days.  In 
eggs MEL levels peaked at a range of 1.6-28.7 mg/kg at day four for all treatments and remained at a 
plateau for as long as the birds had access to the MEL feed.  Similar results were reported by Chen et 
al. (2010) where distribution levels did not differ in eggs from day 1-15, confirming the statement by 
Thompson et al. (2008) that MEL accumulation did not occur.  The distribution levels increased (Bai et 
al., 2010) as the MEL content of the different feeds increased and a similar distribution trend were 
reported for all treatments.   
 
After the withdrawal period was initiated on day 34, MEL levels rapidly decreased in eggs and no 
MEL was detected for treatments receiving 0, 100, 250 and 1000 mg/kg MEL already on day three, 
followed by the treatments receiving 500 and 2000 mg/kg MEL on day four (Bai et al., 2010).  Chen et 
al. (2010) established a linear equation (Y = 0.08491 + 0.01473X) to calculate the MEL distribution 
rate in eggs after receiving a certain level of contaminated feed.  It states that if a feed containing more 
than 164 mg/kg MEL are fed to layers, it is predicted that the residual levels in eggs will exceed the 
maximum permitted level of 2.5 mg/kg (Setiogi, 2008).  Note that 2.5 mg/kg is the maximum limit of 
any veterinary drug that may be traced as a residual in animal tissue or products (Zhu et al., 2009). 
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Lu et al. (2009b) showed that there is a difference in the distribution and metabolism of MEL in eggs 
and other body tissues.  Residues were first detected in egg albumin and the kidney, shortly followed 
by plasma, liver, drumstick and lastly the breast muscle and egg yolk.  Melamine was rapidly 
metabolized and eliminated within the 14 day withdrawal period from the plasma, liver, kidney and 
muscle compared to the albumin and yolk.  On day 21 no samples revealed MEL levels above 0.30 
mg/kg.  A few studies have been conducted to determine the rate of MEL distribution and withdrawal 
from body tissues (kidney, liver, muscle) and the available data has been combined in Table 2 and 
Table 3 to compare the reported results. 
 
Table 2  Comparison between residue results for melamine distribution in poultry meat. 
        Inclusion level (mg/kg) 
¹Day Species Sample type and author   2 100 200 250 500 1000 2000 
Kidney 
42 Broiler   Lü et al. (2009) - 1.7 3.2 - 4.1 9.2 - 
34 Layers   Bai et al. (2010) - 1.3 - 1.6 2.7 8.0 21.7 
40 Broiler   Yuchang et al. (2010) 0.1 4.5 - - - - - 
Liver 
42 Broiler   Lü et al. (2009) - ND ND - 1.3 2.7 - 
34 Layers   Bai et al. (2010) - 0.5 - 0.5 1.5 2.8 6.9 
40 Broiler   Yuchang et al. (2010) - - - - - - - 
Muscle 
42 Broiler   Lü et al. (2009) - ND ND - 1.7 3.7 - 
34 Layers   Bai et al. (2010) - 0.4 - 0.8 1.6 3.7 9.3 
40 Broiler   Yuchang et al. (2010)   0.1 1.7 - - - - - 
¹Day refer to animal age when sample were collected by each author.      
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Table 3  Comparisons regarding the withdrawal rate of melamine from poultry meat. 
        Inclusion level (mg/kg) 
¹Day Species Sample type and author   2 100 200 250 500 1000 2000 
Kidney 
7 Broiler   Lü et al. (2009) - ND ND - ND ND - 
10 Layers   Bai et al. (2010) - ND - ND ND ND ND 
Liver 
7 Broiler   Lü et al. (2009) - ND ND - ND ND - 
10 Layers   Bai et al. (2010) - ND - ND ND 0.06 0.40 
Muscle 
7 Broiler   Lü et al. (2009) - ND ND - ND ND - 
10 Layers   Bai et al. (2010)   - ND - ND ND ND ND 
¹Day refer to animal age when sample were collected by each author.      
 
Lü et al. (2009) noted that MEL were detected on day 28 in breast samples above 200 mg/kg and liver 
samples above 100 mg/kg; however, on day 42 no MEL could be detected in the 200 mg/kg treatments 
and MEL levels were lower for the 500 and 1000 mg/kg group on day 42 compared to day 28 proving 
that MEL do not accumulate in the body and that some sort of mechanism might trigger more rapid 
elimination in the bird.  No illness symptoms or production defects were observed for all treatment 
birds, proving that MEL levels up to 1000 mg/kg are tolerated by birds without affecting production.  
No MEL was detected for treatment groups receiving less than 100 mg/kg. 
 
Various tissue samples were also analyzed for the study of Bai et al. (2010) on day 34 where renal 
tissue displayed the highest concentrations (1.3-21.7 mg/kg) and MEL was also detected in the liver, 
muscle and reproductive organs.  Liver tissue had higher distribution rates compared to muscle for the 
low dose groups; however, more MEL was gradually deposited in muscle than the liver as the dose 
level increased.  After a ten day withdrawal time no MEL was detected in the kidneys and muscle with 
low levels of 0.06 and 0.4 mg/kg in the liver for the treatments receiving 500 mg/kg and 2000 mg/kg 
MEL respectively.  No MEL was detected for any tissue on withdrawal day 20.  Similar findings were 
reported by Yu et al. (2009). 
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2.9.2. Other species and products 
 
After feeding layer ducks different MEL inclusion diets (0, 1, 5, 25, 50 and 100 mg/kg), an increased 
trend in liver and kidney weights were observed as the MEL dosage increased (Yuchang et al., 2010).  
Melamine levels peaked around day two for all treatments and the MEL concentration in eggs were 
higher for the groups that received 25 mg/kg and more compared to the 0-5 mg/kg groups.  The half 
life time of MEL in eggs after withdrawal was found to be 18 hours.  Depleted levels were detected 
four days after withdrawal for all inclusion levels.  The 25, 50 and 100 mg/kg treatments reached the 
0.05 mg/kg detection level after 3, 4 and 8 days respectively.  For the study of Yuchang et al. (2010) 
higher MEL levels were found in poultry eggs compared to kidney and muscle tissue. 
 
In a fish study by Andersen et al. (2008) catfish, trout, tilapia and salmon received 400 mg/kg body 
weight a day in three trials of which MEL or CYAN or MEL-cyanurate were fed for three days.  
Melamine levels of 0.04-0.12 mg/kg were detected in the trout and salmon control fish, due to 
contaminated feed that was fed to the fish six months prior to the initiation of this study.  For trial one, 
fish only received MEL and residual levels were detected in the meat for catfish (210 mg/kg), tilapia 
(177 mg/kg), salmon (94 mg/kg) and trout (80 mg/kg).  After a six day withdrawal period, tilapia had 
considerably lower residual levels (0.02 mg/kg) compared to catfish (81 mg/kg), salmon (58 mg/kg) 
and trout (34 mg/kg).  It could be that tilapia has the ability to excrete MEL more efficient than the 
other fish species.  Or it was likely due to the fact that tilapia emitted some of the MEL containing gel 
food which resulted in decreased ingestion; however, high levels were comparable to catfish.  Trial two 
was similar to trial one except that MEL was substituted with CYAN in the diets fed.  It was interesting 
to note that even though no MEL was detected in the catfish feed, MEL was found in the muscle tissue 
(0.006-0.012 mg/kg).  Salmon also revealed small muscle concentration levels (0.019-0.083 mg/kg); 
however, their feed had been found to be contaminated with 6.7 mg MEL /kg.  No MEL traces were 
found in trout and tilapia.  In trial three all fish received the MEL-cyanurate contaminated diet for three 
days after which a 14 day withdrawal period followed.  In all fish species MEL-cyanurate crystals were 
observed in the kidneys, however the level of crystal formation was considerably different from and 
between species.  Melamine was also detected in muscle tissue of individuals from different species 
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and could be attributed to the level of crystallization where more crystals made less MEL available to 
be deposited in muscle. 
 
It was reported that during 2007 contaminated pet food were used as a supplement in some swine feed 
and contained 30-120 mg/kg MEL (US FDA, 2007).  Even though these levels were declared to cause 
no harm to humans, the public remained cautious of consuming pork.  The half-life excretion rate of 
MEL was reported to be 2.7 hours for rats (Mast et al., 1983) and in pigs 4.04 hours (Baynes et al., 
2008) with a renal clearance of more or less 27 mL/min for pigs, giving a renal clearance difference of 
about 1.5 between the two species.  This is due to the greater renal clearance mechanism of rats which 
is about five times more efficient.  The observed renal clearance findings of pigs as found by Baynes et 
al. (2008) suggests that the distribution of MEL mainly occurs in the extracellular fluid rather than 
being deposited or metabolized by organs, except for the kidney where MEL clearance is made.  They 
also reported that the elimination tempo of MEL from pigs were 1.5 times longer than for rats due to 
different glomerular filtration rates.  The bottom line is that 99% of the MEL occurring in pig blood is 
excreted within 28 hours which is expected to be below the safe level of 50 µL/mL and due to this 
quick excretion rate, distribution of MEL in the muscle and organ tissue (except for the kidneys) is 
expected to be low and should be considered to be safe for consumption. 
 
In goat milk MEL could still be detected after 84 hours of 40 mg/kg ingestion (Baynes et al., 2010) and 
a long plasma half-life (11.12 hours) were reported for small ruminants like goats.  Although the half-
life of MEL in milk was established to be a quick 9.44 hours, detectable levels were still above the 1 
mg/kg safe level for three days.  Therefore MEL elimination in milk could be considered to be of 
higher importance than tissue residues.  In a Holstein cattle study conducted by Cruywagen et al. 
(2009) dairy cattle receiving MEL contaminated feed containing 1142 mg/kg for eight days revealed 
MEL levels of 10-15.7 mg/kg in milk for as long as exposure consisted.  Excretion in milk represented 
2% of the total dose; however, for the goat study by Baynes et al. (2010) only 0.3% of the oral dose 
was recovered in the goat milk, which could be likely due to the lower milk production relative to body 
weight of dairy goats compared to dairy cows.  This statement has been verified by the higher 
percentage of ingested MEL in the milk of high producing goats compared to the low production goats.  
For both studies MEL could be detected in milk for 4-7 days after the last time of exposure.  In another 
dairy study cows received feed containing 50 mg/kg and 100 mg/kg MEL respectively for 28 days 
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(MAFF, 2010).  Milk MEL levels peaked at 0.9 mg/kg and 1.6 mg/kg for the low and high groups 
respectively within two days and rapidly decreased to below 0.01 mg/kg within seven days after 
withdrawal (MAFF, 2010).  Tissue samples were also collected on day 28 for muscle (0.46-0.69 
mg/kg), fat (0.25-0.63 mg/kg), liver (0.58-1.0 mg/kg) and kidneys (2.3-3.4 mg/kg).   
 
After feeding lambs 2-100 mg/kg MEL, maximum levels were reported for muscle (0.435 mg/kg) and 
liver (0.469 mg/kg) samples on day 49 (Lv et al., 2010).  Kidney maximum levels (1067 mg/kg) were 
observed on day 53 which differs from other species.  Treatment groups receiving 2 mg/kg had tissue 
distribution levels below the so called safe level of 0.05 mg/kg.  When MEL intake was discontinued, 
detectable levels below 0.020 mg/kg were reported for all tissue samples within 4.5 days after 
withdrawal.  Except for fish, MEL residues in tissue samples of cattle, swine, chicken, sheep and duck 
exposed to 100 mg/kg a day could not be detected after a four day withdrawal period.  For fish, five 
days for muscle and 14 days for renal tissue were necessary for complete depletion.  Yuchang et al. 
(2010) reported higher residual levels in chicken muscle (1.86 mg/kg) compared to pig (1.36 mg/kg), 
sheep (0.53 mg/kg) and cattle (0.47 mg/kg) after feeding 100 mg/kg MEL per day.  Also eggs had 
more MEL residuals (2.366 mg/kg) compared to milk (0.487 mg/kg); however it was interesting to 
note that chicken, duck and layer muscle tissue samples had the fastest depletion rate of 24 hours 
compared to pigs (48 hours), cattle (65 hours) and sheep (98 hours).   
 
2.10. Cyromazine distribution and withdrawal in animal products 
2.10.1. Poultry meat and eggs 
 
There has been some concern that CYR could be metabolized in poultry breeds to MEL which could be 
deposited in meat and eggs, since it has been reported that 10% of the ingested CYR will convert 
metabolically to MEL (USEPA, 2007).  Chou et al. (2003) tested chicken, egg, beef, mutton and pork 
samples for any CYR and MEL residues.  None of the samples revealed detectable MEL levels (> 0.02 
mg/kg) and only one beef sample contained 0.04 mg/kg CYR.  
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Cyromazine were detected (100 mg/kg) in layer eggs after feeding 2.5 mg CYR /kg feed/day for five 
weeks (Miller & Corley, 1980) and no traces were found in liver or muscle tissue.  It was concluded 
that there is a positive correlation between induced dose levels and residues in eggs.  Cyromazine was 
also detected in the liver, muscle and faeces after an increase in inclusion level.  In a study by 
Anderson et al. (1987), CYR (0.00044 mg/kg added to diet) traces were found in only three out of 32 
eggs with detection levels of <0.01, 0.11 and 0.22 mg/kg respectively and no traces were found in the 
thigh and breast portions and the liver, gizzards and fat.  These findings might not be considered 
accurate since tissue samples were harvested from only two birds; however, these results have the same 
trend as the previous mentioned trial of Miller and Corley (1980). 
 
Cecil et al. (1981) determined the amount of CYR distribution in the liver, fat and muscle of layers 
after feeding a CYR derivate known by the industry as CGA-19255 at four different levels (2.5, 12.5, 
25 and 125 mg/kg).  CGA-19255 is metabolized in the body to CYR.  Cyromazine were not traced in 
the first group and increasing levels were found in the liver and muscle as a result of increased 
administration levels.  Cyromazine deposition in fat was only detected after 125 mg/kg ingestion of 
CGA-19255.    No CYR were detected after only a week of withdrawal in all tissues for all treatment 
levels and the authors concluded that these inclusion levels did not suppress any production 
performance qualities.  No MEL was detected in any egg or meat samples in the study of Boone et al. 
(1985) after feeding layers 0-5 mg/kg CYR.  The CYR maximum levels were already reached on day 
three in eggs and day 14 in meat samples.  Withdrawal times were rapid and within one and two days 
no CYR were detected in meat and eggs samples respectively. 
 
Even though CYR is rapidly eliminated from the body as mentioned under section 2.6, undeniable 
evidence published by Brake et al. (1991) shows that contaminated faeces were passed several weeks 
after birds were withdrawn from a diet containing CYR.  The higher the administered dose, the longer 
the residual toxicity duration persisted.  Brake et al. (1991) reported that when feeding layers 25 
mg/kg/day CYR for the first 20 weeks of age, residuals could be found in the droppings 13 weeks after 
CYR withdrawal and it was suggested that residues were deposited in body tissues.  The recycling of 
CYR might have occurred since the birds were reared on the floor and according to the later studies of 
Caldas (2007) 97% of ingested CYR (5 mg/kg) are excreted within 24 hours.  Although the inclusion 
levels in the study of Caldas (2007) were only 5 mg/kg which might have relieved some renal pressure 
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to manage CYR excretion compared to the 25 mg/kg applied by Brake et al. (1991), the delay in CYR 
excretion reported by Brake et al. (1991) is questionable since contamination could repeatedly occur by 
ingesting faeces containing CYR. 
 
2.10.2. Other species and products 
 
In studies on other species, findings similar to the poultry trials were reported.  In a lactating goat study 
by Simoneaux et al. (1984), a low (4.8 mg/kg) and high (48 mg/kg) CYR concentration were 
administered to two groups.  Approximately 90.4% and 82.2% of the recovered residues were excreted 
via urine and 7.5% and 5.7% in the faeces respectively for the low and high doses.  Less than 2% of the 
administered dose was recovered in body tissue.  Again the liver had the highest residue levels (0.791 
mg/kg and 1.522 mg/kg) followed by kidney tissue (0.043 mg/kg and 0.437 mg/kg) and loin cuts 
(0.009 mg/kg and 0.104 mg/kg).  Cyromazine detected in the milk accounted for 0.2% of the total 
recovery with an average of 0.017 mg/kg for the low dose and 0.35 mg/kg for the high CYR dose.  In a 
similar study by Tortora (1991), 150 mg/kg were administered to dairy goats which is higher than the 
dose provided by the previous researcher.  Also Tortora (1991) had a lower recovery rate of 73.9% 
compared to Simoneaux et al. (1984) (102% and 90.4% for the low and high dosed animals 
respectively).  The highest recoveries were in the kidneys (3.78mg/kg) followed by the liver (0.93 
mg/kg) and loin cut (0.79 mg/kg) which is contradictory to the higher liver recovery rates of 
Simoneaux et al. (1984).  Milk contained 0.76 % of the total recovery (0.656 mg/kg).  These studies 
added to the confirmation that higher administered CYR doses will result in higher residual traces as 
mentioned before.  Melamine was also detected in the kidney (1.24 mg/kg), liver (0.16 mg/kg) and loin 
cut (0.03 mg/kg) as a result of CYR metabolism in vivo.  No MEL was detected in fat and CYR levels 
were 0.11 mg/kg. 
 
In a small study on sheep, 5 mg/kg CYR were administered for nine days on only one sheep 
(Simoneaux et al., 1981).  The results were similar to the goat studies.  The liver yielded the highest 
CYR recovery (0.174 mg/kg) followed by the kidneys (0.048 mg/kg) and leg muscle (0.013 mg/kg).  It 
was interesting to note that a higher level of MEL was detected in the liver (0.645 mg/kg) compared to 
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CYR, which might be explained by the relatively low recovery rate of 67% that could have influenced 
accurate detection. 
 
No detectable CYR residues were found in rat tissue after feeding 0.5 mg/kg CYR (Simoneaux et al., 
1978), except for the liver (0.007 mg/kg); however, the author discarded this value due to a lack of 
accuracy.  Caldas (2007) proposed a possible pathway for CYR metabolism in different animal species.  
In the rat, goat, hen and sheep CYR can be metabolized to MEL; however, very little data on these 
reports are available.  Only in rats and goats the residual methyl-CYR were observed and goats were 
the only animal investigated to have hydroxyl-CYR present as a CYR metabolite. 
 
2.11. Melamine and cyromazine contamination due to processing and food package material 
 
In cattle MEL levels of 0.010-0.170 mg/kg were reported due to the ingestion of CYR.  Processing and 
curing of beef containing CYR seemed to help reduce the CYR content by 35% (Epstein et al., 1988).  
The author also reported that beef processing at 68°C increased the CYR content of the product due to 
water loss.  A MEL trace of 1 mg/kg were found in canned beef that were treated with and without 
CYR and the possible explanation was that it could be contaminated by the MEL-formaldehyde resin 
originating from the can lining.  The US FDA (2007) allows MEL-formaldehyde coatings as long as 
the chloroform soluble extractives yield does not exceed a food contact surface of 0.5 mg/inc2.  Zhu et 
al. (2009) could however not trace any MEL back to their milk containers and therefore the 
contaminated milk was not due to packaging materials.  Lu et al. (2009a) also reported no MEL levels 
in milk migrated from containers, polypropylene and polycarbonate materials.  Low levels were 
detected in milk samples packed in MEL resin containers and it was reported that these results met the 
European Unit’s requirements. 
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2.12. Conclusion 
 
It has been reported that MEL and CYR are rapidly eliminated by the body via urine.  Small doses of 
MEL are tolerable in most animals; however it has been widely reported that levels above 1000 mg/kg 
can cause severe kidney damage and other adverse production effects. The kidneys appeared to be 
damaged more severly by MEL-cyanurate followed by MEL and CYR.  Altough no clinical defects 
were reported after ingesting high levels of CYR, some production parameters were adversly affected, 
indicating that CYR should be used with caution as a feed additive in layer diets. 
 
A definite trend exists for the distribution of MEL in meat and other animal products.   It appears as if 
MEL are rapidly noticed (within a day or two) in products such as eggs and milk followed by muscle 
tissue.  There is also a link between the level of MEL exposure and the concentration deposited.  The 
higher the administered MEL levels, the more MEL is deposited in the eggs, milk and meat.  Also it 
has been found that MEL residues increased rapidly in animal products up to a certain point where 
after it reaches a plateau where no further increases are noted.  These finding  led to the conclusion that 
MEL does not accumulate in the body and that some sort of mechanism exists to help the animals to 
manage the ingested MEL. 
 
After MEL administration is terminated, MEL is rapidly removed from meat (within four days) and 
eggs (within 7-10 days) and therefore chickens reared on MEL contaminated feed could still be 
marketed if a sufficient withdawal time was allowed prior to slaughter.  From the literature CYR is 
probably not metabolized and deposited as MEL in animal tissues or eggs; however, in theory a small 
proportion could be deposited as MEL.  The literature covering this specific field was extremely 
limited regarding the latter and the possibility of CYR being metabolized to MEL in animal products 
remains uncertain. 
 
The toxicity sensitivity level between animal species varied greatly and residuals remained longer in 
animal products such as milk and eggs rather than muscle tissue after withdrawal.  Rats metabolize 
MEL the fastest followed by chickens and pigs and small ruminants such as goats and sheep have the 
longest half life for MEL excretion compared to all the other investigated animal species. 
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Many studies reported on the rate of MEL distribution and many similar rates were comparable while a 
few contraditions exist; however, all results only sketch a vague picture accompanied with many 
assumptions.  Prediction models have also been formulated for rats and pigs to estimate MEL 
distribution and withdrawal rates; however, further investigation is required to refine this field.  
Although alot has been learned on the distribution and withdrawal times in many species as well as the 
characteristic toxicity symtoms, the exact mechanism of MEL and CYR metabolism still needs to be  
confirmed.  More accurate distribution and withdrawal rates should also be established in order to 
guide the industry on MEL and CYR safety levels. 
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3. CHAPTER 3                                                                          
Absorption of dietary melamine and cyromazine and subsequent distribution to 
in poultry meat 
 
3.1. Introduction 
 
Melamine (C3H6N6) is an organic industrial chemical with many applications, but it is mainly used to 
manufacture paints, laminates, table tops and other plastic ware.  Melamine has an exceptionally high 
N content of 667g/kg on a molecular weight basis (Merck, 2001), which relates to a crude protein (CP) 
content of 4169 g/kg (N x 6.25).  This is approximately 45% higher than the CP content of urea.  
Therefore, the opportunity emerged to add this substance to high protein feed products such as infant 
formula (WHO, 2008), wheat gluten, corn gluten, rice protein (Weise et al., 2007), soya and fishmeal 
(CBC News, 2007).  These products were mainly used for animal feed production. 
 
In South Africa, maize gluten meal (also known as Gluten 60 or Prime Gluten) is the only known 
imported feed ingredient where MEL contamination could be confirmed.  Approximately 50 000 tons 
of maize gluten is annually used for animal feed manufacturingin South Africa (Briedenhann, 2010).  It 
is not exactly clear how much of the adulterated gluten 60 was imported during 2008, but the 
Department of Agriculture has confiscated some 300 tonnes.  Despite the misuse of MEL as feed 
adulterant, concern has been expressed that MEL might end up in animal tissues as a result of 
cyromazine (CYR) ingestion, as MEL is an intermediate compound of CYR metabolism in the animal.  
Cyromazine is the active ingredient of some pesticides such as Larvadex® which is commonly added to 
poultry layer feed to inhibit fly larvae from hatching in the manure.  Furthermore, MEL can be present 
in pelleted feed as binding agent or in minute quantities as a result of migration from the environment 
(WHO, 2008).  Groundbreaking work confirmed the distribution of MEL from feed to broiler meat  
(Bai et al., 2010; Chen et al., 2010; Lüet al., 2009a and Yuchang et al., 2010).  In another study, Boone 
et al. (1985) determined MEL residues in meat which might have been the result of the metabolization 
of ingested CYR.  
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The popularity of broiler meat consumption increases annually in South Africa with a total production 
of 931 443 000 broilers during 2009 (Vauqulin, 2010) and new processed chicken products are 
consistently demanded.  This seems to be proof that the impact of MEL included in broiler feed is far 
beyond the impact scope that manufactures could have ever imagined and this is only one division of 
many that are contributing to the food chain.  It would be of interest to feed manufacturers to asses the 
inclusion of MEL and CYR in broiler feeds and to determine the distribution pathways of these two 
substances in meat to be able to implement the necessary safety measures.   
 
Therefore, the objectives of this study were: 
1. to determine the distribution efficiency of MEL from feed to chicken meat and the effect of 
MEL on production responses when MEL was added to broiler diets at different levels, 
ranging from 0 to 500 mg/kg. 
2. to determine if MEL would be cleared from the meat after contaminated feed had been 
withdrawn. 
3. to compare the distribution of MEL in different tissues (liver, kidneys and muscle). 
4. to explore the possibility of MEL detection in muscle tissue as a result of CYR metabolism 
by including Larvadex® in one of the experimental diets. 
 
3.2. Materials and methods 
 
All feeding, husbandry and harvesting methods were practised strictly according to the ethical 
requirements that have been approved by Subcommittee B of the University of Stellenbosch 
(Reference # 2008B03003).  The Larvadex® product contained 99% inert products and only 1% CYR 
(Drugs.com, 2010).  Since it was recommended by the suppliers (Profile Feeds, Paarl, South Africa) 
that Larvadex® should be included at 400 mg/kg, the CYR treatment therefore effectively received 4 
mg/kg CYR, which is within the maximum legal level of 5 mg/kg (Drugs.com, 2010).     
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3.2.1. Birds, housing and management 
 
A total number of 480 day old Cobb 500 chickens were obtained from a local hatchery (Vredebest 
Farms, Stellenbosch).  On arrival, the birds were vaccinated for Infectious Bronchitis and placed 
promptly to minimize further travelling stress.  Environmental temperature and lighting regimes were 
applied according to the Cobb 500 guidelines of 2010.  All birds received a balanced pre-starter diet 
(Table 4) until Day 9.  The diet was offered ad libitum and it contained no detectable levels of MEL or 
CYR.  Water was freely available at all times via 250 mL cups and after Day 18 via nipple drinkers.  
On Day 9, four chicks were randomly allocated to each of 120 cages after which the cages, which were 
regarded as experimental units, were randomly assigned to five treatments.   
 
3.2.2. Treatments and experimental diets 
 
The five experimental treatments were as follows: 
 
1. Treatment 1 (CON) received a diet containing no detectable levels of MEL or CYR. 
2. Treatment 2 (MEL50) received a diet containing 50 mg/kg MEL and no CYR. 
3. Treatment 3 (MEL100) received a diet containing 100 mg/kg MEL and no CYR. 
4. Treatment 4 (MEL500) received a diet containing 500 mg/kg MEL and no CYR. 
5. Treatment 5 (CYR4) received a diet containing 4 mg/kg CYR and no MEL. 
 
Diets were mixed on the Mariendahl Experimental Farm of the Stellenbosch University.  Maize gluten 
meal imported from China found to be an adulterated product (Cruywagen & Reyers, 2009), was used 
as one of the MEL sources in the diets.  The MEL content of the product was 15 117 mg/kg.  It also 
contained urea, wheat bran, maize bran, gluten 20 and actually very little gluten 60.  Because of the 
nature of the product it was thus decided to limit the inclusion level thereof and to balance the required 
MEL content of the diets with pure MEL (Sigma-Aldrich M2659, Supplied by Sigma, Cape Town).  
The minor ingredients were carefully weighed out and mixed in an industrial blender with a 10 kg 
capacity.  The mixture was then transferred to a vertical industrial mixer (1 tonne capacity) and the 
major ingredients were added.  First, the CON diet was mixed followed by the CYR4, MEL50, 
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MEL100 and lastly the MEL500 diet to avoid contamination between diets.  All feeds were presented 
as a meal and stored in a cool dry area in 50 kg bags. 
 
The pre-starter diet was offered ad libitum to all the chickens until Day 9 when the different 
experimental diets were introduced.  Chickens received the respective starter diets from Day 9 until 
Day 18, the grower diets from Day 19 to 28 and the finisher diets from Day 29 until Day 36 – all these 
diets being offered ad libitum. 
 
Chicken mortalities and morbidities were recorded throughout the trial and feed intake was determined 
by measuring the total amount of starter, grower and finisher feed that each treatment had consumed 
for the duration of the trial.  On Day 19 birds were moved to a similar house with larger pens.  Intake 
was not influenced after this move and it is accepted that the stress of moving did not have an adverse 
effect. 
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Table 4  The composition and calculated analysis (g/100g “as fed”) of broiler diets in the melamine trial. 
  Ration Name 
Pre-starter Starter diet treatments1 Grower diet treatments Finisher diet treatments
Item All 1 2 3 4 5 1 2 3 4 5 1 2 3 4 5
Ingredient   
   Maize Gluten 602 - - 0.02 0.02 0.02 - - 0.33 0.67 2.50 - - 0.33 0.67 3.00 - 
   Melamine3 - - - 0.01 0.05 - - - - 0.01 - - - - 0.01 - 
   Larvadex - - - - - 0.04 - - - - 0.04 - - -  0.04 
   Vit+Mineral Premix4 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 1.24 
   Maize 43.4 49.9 49.9 49.9 49.8 49.9 50.4 50.0 49.7 47.7 50.4 58.8 58.4 58.1 55.7 58.8 
   Soybean Full Fat 50.8 42.1 42.1 42.1 42.2 42.1 29.0 29.0 29.0 29.0 29.0 1.24 1.26 1.28 9.24 1.24 
   Soybean 46 1.02 3.36 3.35 3.34 3.26 3.34 16.4 16.5 16.5 16.7 16.4 35.8 35.8 35.8 27.9 35.8 
   L-lysine HCl 0.41 0.37 0.37 0.37 0.37 0.37 0.12 0.11 0.11 0.08 0.12 0.07 0.07 0.06 0.09 0.07 
   DL-methionine 0.26 0.23 0.23 0.23 0.23 0.23 0.15 0.14 0.14 0.10 0.15 0.10 0.09 0.08 0.06 0.10 
   L-threonine 0.15 0.13 0.13 0.13 0.13 0.13 - - - - - - - - - - 
   Limestone 1.62 1.66 1.66 1.66 1.66 1.66 1.66 1.66 1.66 1.66 1.66 1.71 1.71 1.71 1.71 1.71 
   Salt 0.15 0.21 0.21 0.21 0.21 0.21 0.25 0.25 0.25 0.25 0.25 0.23 0.23 0.23 0.24 0.23 
   Monocalcium Phosphate 1.63 1.64 1.64 1.64 1.64 1.64 1.64 1.64 1.64 1.63 1.64 1.65 1.65 1.65 1.64 1.65 
   Sodium Bicarbonate 0.30 0.21 0.21 0.21 0.21 0.21 0.16 0.16 0.16 0.15 0.16 0.18 0.18 0.18 0.17 0.18 
Calculated composition                 
   AMEn (MJ/kg)5 13.0 12.8 12.80 12.8 12.8 12.8 12.0 12.0 12.0 12.0 12.0 11.3 11.3 11.3 11.8 11.3 
   Crude Protein 23.6 22.0 22.0 21.97 22.0 22.0 22.8 23.0 23.2 24.2 22.8 22.1 22.3 22.4 23.0 22.1 
   Calcium 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
   Total phosphorus 0.82 0.82 0.82 0.82 0.82 0.82 0.82 0.82 0.82 0.82 0.82 0.82 0.82 0.82 0.82 0.82 
   Available phosphorus 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 
   Digestible lysine 1.51 1.37 1.37 1.37 1.37 1.37 1.24 1.24 1.24 1.24 1.24 1.14 1.14 1.14 1.14 1.14 
   Digestible methionine 0.55 0.51 0.51 0.51 0.51 0.51 0.45 0.45 0.43 0.45 0.40 0.40 0.40 0.40 0.39 0.40 
   Melamine 0.00 0.00 0.005 0.01 0.05 0.00 0.00 0.005 0.01 0.05 0.00 0.00 0.005 0.01 0.05 0.00 
1Treatments:  1 = no added melamine; 2 = dietary melamine 50 mg/kg; 3 = dietary melamine 100 mg/kg; 4 = dietary melamine 500 mg/kg; 5 = dietary cyromazine 4 mg/kg. 
2The maize gluten 60 contained melamine at a level of 15117 mg/kg. 
3Melamine powder (Sigma-Aldrich M2659, Supplied by Sigma, Cape Town). 
4Vitamin+mineral premix provided (per kg of diet): 8160 IU vitamin A, 1700 IU vitamin D3, 30.6 IU vitamin E, 2.7 mg vitamin K3, 2.05 mg vitamin B1, 2.05 mg vitamin B2,  
  27.2 mg niacin, 10.2 mg calcium pantothenate, 0.02 mg vitamin B12, 4.1 mg vitamin B6, 1.7 mg folic acid, 0.068 mg biotin, 120 mg ronozyme p500, 350 mg choline,  
  0.08 mg I, 0.34 mg Co, 0.2 mg Se, 70 mg Mn, 70 mg Zn, 6 mg C and 50 mg Fe. 
5AMEn = Apparent metabolizable energy. 
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Samples (100 g) were collected before the start of the trial from all the experimental diets and milled 
through a 1 mm screen after which the diets were analyzed to confirm MEL inclusion levels using the 
LC-MS/MS method (described later).  The obtained values are displayed in Table 5. 
 
Table 5  The expected and analyzed melamine values (mg/kg) of the diets for trial purposes. 
  Analyzed value 
Treatment1 Expected value Pre-Starter Starter Grower Finisher 
1 0 ND ND ND ND 
2 50  36.24 60.12 82.16 
3 100  118.2 116.2 124.9 
4 500  356.5 543.2 656.3 
5                   0                                                  ND ND ND 
1Treatments:  1 = no added melamine; 2 = dietary melamine 50 mg/kg; 3 = dietary melamine 100 mg/kg; 4 = dietary melamine 500 
mg/kg; 5 = dietary cyromazine 4 mg/kg. 
 
3.2.3. Measurements and sampling 
 
To determine the rate at which MEL could be disturbed to body tissues, six birds were euthanized 
from each treatment (except for CYR4) on Days 11, 13, 15, 18, 22, 29 and 36 (Figure 3). 
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         Day 11        Day 13        Day 15        Day 18        Day 22        Day 29        Day 36 
CON            6 birds         6 birds        6 birds         6 birds         6 birds        6 birds         6 birds 
MEL50        6 birds         6 birds        6 birds         6 birds         6 birds        6 birds         6 birds  
MEL100      6 birds         6 birds        6 birds         6 birds         6 birds        6 birds         6 birds  
MEL500      6 birds         6 birds        6 birds         6 birds         6 birds        6 birds         6 birds  
CYR4                                      6 birds 
1C18 (MEL50, MEL100, MEL500)            18 birds  
C22 (MEL50, MEL100, MEL500)            18 birds 
C29 (MEL50, MEL100, MEL500)                       18 birds 
 
Figure 3  Diagrammatical illustration of the slaughtering process of broiler birds in the melamine 
trial.  1C18; C22; C29 = Birds slaughtered on day 36 received the control diet from Day 18, Day 22 or 
Day 29, respectively. 
 
The rate at which MEL could be cleared from the respective tissues was investigated by replacing the 
MEL diet with the control diet for the remaining chickens from the cages that were selected for 
slaughtering on Days 18, 22 and 29.  These birds were then slaughtered on Day 36 to establish a MEL 
withdrawal period of 18, 14 and 7 days, respectively.  Regarding CYR4, it should be mentioned that 
only the possibility of MEL being detected as a metabolite (derived from cyromazine) in the liver, 
kidneys and the breast muscles were of interest, rather than the rate at which it would be distributed to 
the various tissues.  Therefore, birds from CYR4 were only slaughtered on Day 36 and these results 
compared to the CON treatment. 
 
Birds were weighed before slaughter and were euthanized by means of the cervical dislocation 
technique.  The pectoralis major and minor muscles, liver (without the gallbladder), heart, spleen and 
the kidneys were removed and weighed.  Only the breast, liver and kidney samples were analyzed for 
Birds not slaughtered on these days were 
switched back to the control diet  
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MEL residues and these samples were promptly frozen at -18°C.  The same sampling technique and 
procedure were applied for dissected CYR4 birds on Day 36. 
 
3.2.4. Laboratory analyses 
 
The frozen samples were thawed overnight and then cut into pieces to increase evaporation area.  The 
correct technique would have been to homogenize the samples; however, most of the samples were 
too small for effective homogenization and nonetheless the dried samples were milled as described 
later.  The samples were weighed and dried in an oven (Memmert, 220V, 2000W, 0-280°C, West-
Germany) at 50-59°C in small aluminium foil dishes.  Temperature readings from the top and bottom 
sections of the oven revealed the inevitable variation as stated.  The nitrogen compounds of the tissue 
samples may become volatile above 60°C; therefore, the differences in temperature reported were 
assumed not to have affected the results.  All the samples were dried to constant weight.  The livers 
required more than 48 hours to dry, due to their high fat content.  The kidneys required only 24 hours 
drying time, while for the breast samples, 33 hours were sufficient.  The reason for using the oven 
drying method instead of freeze-drying was due to limited freeze-drying capacity and that oven drying 
seemed to be as efficient as freeze-drying. 
 
The dried samples were ground with a mill (Russel Hobbs Model no. 10934 obtained from a local 
retail store) until a powdery texture was obtained.  These samples weighed between 1.92 and 91.50 g.  
The average percentage moisture loss for the breast and kidney samples were similar (73.80% and 
73.84% respectively) and for the livers only 65.22%, emphasising the high fat contents of the latter 
once more.  All the samples were frozen again in plastic bags at -18°C for further analyses.  
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For MEL analysis, the method described by Shai et al. (2008) was used with some modifications.  
Cruywagen et al. (2009) described the method as follows: 
 
Chemicals and Reagents: 
− 1 g ground sample 
− 50% Acetonitrile 
− 10 mL0.1% formic acid 
− Methanol (12 mL) 
− Water (6 mL) 
− 100 µL of a 0.5 mg/L stable isotope labelled MEL (13C3H615N3) internal standard solution 
(Cambridge Isotope Laboratories, Inc., Andover, MA) 
− 0.1N HCl (6 mL) 
− 6 mL ammonium hydroxide:methanol:dichloromethane (1:5:5) 
− 1 mL acetonitrile (50%). 
− Nitrogen 
 
Other Consumables and Equipment: 
6. Ultrasonic bath 
7. Standard 24 –port vacuum manifold (Vac Elut SPS 24) 
8. Cation exchange solid phase extraction (SPE) cartridges (Phenonenex Strata SCX, 55 µm, 
70 A, 500 mg/3 mL, supplied by Separations, Randburg, South Africa) 
9. Tubes (15 mL glass) 
10. Waters API Quattro Micro triple quadruple mass spectrometer 
11. Waters 2690 HPLC (Waters Corporation, Milford, MA) 
 
Method: 
− The grounded samples (1 g) were extracted with 50% acetonitrile (10 mL) and 0.1% 
formic acid (10 mL) by sonication in an ultrasonic bath for an hour. 
− The cation exchange SPE cartridges were then conditioned with 6 mL methanol followed 
by 6 mL water. 
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− The cartridges were washed with 6 mL of 0.1 N HCL and 6 mL methanol respectively 
while aspirating under vacuum for one minute. 
− The MEL were then eluted with 6 mL ammonium hydroxid:methanol:dichloromethane 
(1:5:5) into a clean tube.  
− The extracts were dried for 48 hours in a fume cupboard and resuspended in 1 mL of 50% 
acetonitrile. 
− The samples were analyzed with liquid chromatography–tandem mass spectrometry (LC-
MS/MS) on the Waters API Quattro Micro triple quadruple mass spectrometer, coupled to 
a Water 2690 high performance liquid chromatographer (HPLC).  
− For tissue samples, the detection limit of this method was 0.05 mg/kg. 
− The internal standard was used to correct dissimilarities in recovery rates. 
 
Several other methods (i.e. Capillary electrophoresis; gas chromatography and gas chromatography–
mass spectrometry) have been suggested to determine the presence of MEL in various media (Xia et 
al., 2009).  However, the LC–MS/MS method is the most accurate one for determining MEL in 
muscle (Smoker & Krynitsky., 2008) and kidney (Filigenzi et al., 2008). 
 
3.2.5. Statistical analyses 
 
All the data were analyzed using the Statistica Version 9 (2010) package.  Production data, as well as 
MEL concentration in meat data, were subjected to a two-way ANOVA (where treatment and day 
were the main effects) using the general linear models (GLM) procedure.  Since the MEL residues 
observed in slaughtered birds (experimental unit) were independent of each other on the different 
slaughter days, the repeated measures analysis method was considdered as inappropriate.  
Comparisons between the liver, kidney and muscle tissues were performed by implementing the 
repeated measures of analysis method.  Due to the fact that no MEL could be detected in samples 
from birds subjected to withdrawal, CON and CYR4, no statistical analyses were performed on these 
data.   
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3.3. Results 
 
3.3.1. Production parameters 
 
The following production parameters were recorded:  feed intake, weight gain, feed conversion ratio 
(FCR), mortality, protein efficiency and European production efficiency (EFEF). No visible 
differences occurred between treatments.  Because significant treatment x day interactions was 
observed, the main effects cannot be interpreted for feed intake.  It appeared, however, that CYR4 
chickens had a greater appetite, which is confirmed by the fact that on Days 13, Day 18 and Day 22 
the CYR4 chickens had a significantly (P < 0.01) higher feed intake than those in any of the other 
treatments.   Some vomiting was noted from a few birds that ingested the MEL diets and similar 
observations in dogs and cats were reported by Brown et al. (2007) and Hau et al. (2009). 
 
Table 6  Average daily feed intake (g/d) of broilers in the melamine trial. 
 Day 
1Treatment 11 13 15 18 22 29 36 
1 27.7a 34.8d 48.7f 72.2h 92.5j 136.7lm 169.3n 
2 28.0ab 31.5abcd 47.2f 70.8h 91.8j 135.3l 167.0n 
3 29.7abc 33.8d 48.3f 71.0h 89.7j 136.8lm 168.8n 
4 27.7a 31.8bcd 53.0g 71.5h 92.8j 134.8l 167.3n 
5 33.0cd 41.0e 56.0g 83.3i 106.7k 140.0m 168.0n 
1Treatments:  1 = no added melamine; 2 = dietary melamine 50 mg/kg; 3 = dietary melamine 100 mg/kg; 4 = dietary melamine 500    
  mg/kg; 5 = dietary cyromazine 4 mg/kg. 
a-nMeans within rows and columns with different superscripts differed significantly (P < 0.01). 
 
 
The cumulative feed intake was recorded and average daily feed intakes were calculated, which are 
shown in Figure 4. 
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Figure 4  Average daily feed intake (g/d) of broilers in the melamine trial.  Treatments:  1 = no added 
melamine; 2 = dietary melamine 50 mg/kg; 3 = dietary melamine 100 mg/kg; 4 = dietary melamine 
500 mg/kg; 5 = dietary cyromazine 4 mg/kg. 
 
No differences between treatments were recorded for live weight (Table 7).  As expected, significant 
differences (P < 0.01) were obtained between days, except for Days 11 and 13.   
 
Table 7  The cumulative weight gain (g/d) of broilers in the melamine trial. 
 Day  
Treatment 11 13 15 18 22 29 36 P 
1 239.7a 310.0a 396.8b 553.0c 666.7d 1309.3e 1756.0f <0.01 
2 290.5a 287.8a 389.7b 595.0c 719.2d 1189.5e 1750.5f <0.01 
3 297.7a 309.0a 374.7b 588.2c 703.7d 1235.7e 1822.2f <0.01 
4 241.3a 296.7a 400.8b 549.0c 760.2d 1171.2e 1728.1f <0.01 
1Treatments:  1 = no added melamine; 2 = dietary melamine 50 mg/kg; 3 = dietary melamine 100 mg/kg; 4 = dietary melamine 500    
  mg/kg; 5 = dietary cyromazine 4 mg/kg. 
a-fMeans within rows and columns with different superscripts differed significantly (P < 0.01). 
 
 
54 
 
The feed conversion ratio was calculated by dividing the cumulative feed intake (g) by the total live 
weight gain (g).  No significant differences were found between treatments for FCR at termination -  
Day 36 (Table 8).  Regarding mortality, only four birds died during the trial and two had to be culled 
due to leg abnormalities.   
 
Table 8  The production results of feed conversion ratio (FCR), protein efficiency rate and European 
production efficiency rate (EPEF). 
 Treatment 
Parameter  1 2 3 4 5 P 
FCR 1.61 1.34 1.49 1.53 1.47 0.26 
Protein efficiency (%) 2.97a 2.86a 2.77a 2.82a 3.40b 0.049 
EPEF  296 319 335 310 334 0.90 
a-fMeans within rows with different superscripts differed significantly (P < 0.05). 
 
 
The protein efficiency ratio (grams body weight gain / grams protein ingested, expressed as a 
percentage) was also calculated as an additional measurement of the production performance (Table 
8).  The crude protein level of the finisher feed was 19.26 %.  The results indicated that CYR4 
differed (P < 0.05) from all the other treatments with the best protein efficiency.   
 
Finally, production efficiency was calculated by means of the European Production Efficiency Factor 
(EPEF) in order to establish a broader broiler performance rate (Perić et al., 2009). 
 
EPEF = (end weight – start weight) x (100 – mortality %) / (days in production x FCR x 10) x 1000 
 
The EPEF for all treatments were satisfactory and none of the treatments differed from each other.  
Therefore it seems as if MEL and CYR inclusion in the diet did not have a marked effect on 
production overall. 
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3.3.2. Melamine concentration in muscle tissue 
 
The MEL concentrations detected in breast meat are displayed in Table 9.  No MEL could be detected 
in the withdrawal groups on day 36 or in the CYR4 treatment on day 36.  These results were therefore 
not included in the statistical analyses. 
 
Table 9  The concentration of melamine (mg/kg dry weight) in breast meat after feeding diets 
containing graded levels of melamine over time. 
Day 
Treatment1 11 13 15 18 22 29 36 P 
1 ND2 ND ND  ND ND ND ND  
2 4.4 ± 1.73 3.7 ± 1.3 4.6 ± 1.0 4.3 ± 0.8 7.1 ± 1.7 4.1 ± 1.9 2.7 ± 0.6 0.018 
3 7.6 ± 2.5 6.6 ± 2.8 7.9 ± 2.2 7.4 ± 1.5 11.9 ± 3.4 9.4 ± 3.8 5.0 ± 1.0 0.018 
4 38.2 ± 17.5 45.3 ± 13.0 22.8 ± 16.1 34.9 ± 10.8 52.5 ± 6.7 33.1 ± 15.7 27.1 ± 9.1 <0.001 
5 - - - - - - ND  
P 0.2 0.3 0.2 0.3 0.04 0.3 0.2  
1Treatments:  1 = no added melamine; 2 = dietary melamine 50 mg/kg; 3 = dietary melamine 100 mg/kg; 4 = dietary melamine 500   
 mg/kg; 5 = dietary cyromazine 4 mg/kg. 
2ND = Not detected.  The detection limit of the method was 0.05 mg/kg.  
3Data are displayed as means ± SD (n = 6).  
 
The MEL distribution levels in breast meat increased as the feed MEL concentration increased (Figure 
5).  An interaction (P < 0.05) was observed between treatments and days.   
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Figure 5  An illustration of the mean distribution values (mg/kg) of melamine in muscle after 
ingesting diets containing graded levels of melamine over time (day).  a-hMeans with different 
superscripts differed significantly (P < 0.05).  Treatments:  1 = no added melamine; 2 = dietary 
melamine 50 mg/kg; 3 = dietary melamine 100 mg/kg; 4 = dietary melamine 500mg/kg; 5 = dietary 
cyromazine 4 mg/kg. 
 
 
For each day tested, MEL500 differed (P < 0.05) from MEL50 and MEL100 whilst the latter two did 
not differ from each other.  Within MEL500, differences occurred as indicated by Figure 5.  Within 
MEL500, Day 22 differed (P < 0.01) from all the other days except for Day 13.  Also Day 15 differed 
(P < 0.05) from Days 11, 13, 18 and 22.  During slaughter on Day 15 it was noted that the 
gallbladders of all the birds of MEL500 were enlarged compared to MEL50 and MEL100.  Day 13 
differed from Days 28 (P < 0.05) and 36 (P < 0.01) and Day 11 also differed (P < 0.05) from Day 36.  
It was interesting to note that on Day 22 a peak concentration level for all treatments were achieved 
after which a definite decline can be observed until Day 36. 
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3.3.3. Melamine concentrations in liver and kidneys 
 
Melamine concentrations in the liver and kidneys were only tested on Day 36 (Table 10).   Since it 
was assumed that no MEL would be detected in the CON treatment samples, these samples were not 
tested for MEL residues. 
 
Table 10  The concentration melamine (mg/kg dry weight) in breast meat, liver and kidneys of 
broilers that received diets with graded levels of melamine. 
 Tissue 
Treatment1 Muscle Liver Kidney 
2 22.72 a ± 0.59 1.57 a ± 0.57 10.28 b ± 2.10 
3 4.99 ab ± 0.97 2.88 a ± 0.96 16.7 c ± 3.49 
4 23.5 d ± 9.12 16.9 c ± 6.21 73.0 e ± 9.55 
P  0.29 0.29 < 0.01 
1Treatments:  1 = no added melamine; 2 = dietary melamine 50 mg/kg; 3 = dietary melamine 100 mg/kg; 4 = dietary melamine 500   
 mg/kg; 5 = dietary cyromazine 4 mg/kg. 
2Data are displayed as means ± SD (n = 6).  The detection limit of the current study was 0.05 mg/kg. 
a-hMeans within rows and columns with different superscripts differed significantly (P < 0.05). 
 
 
From Table 10 it is evident that the kidneys had significantly higher (P < 0.05) MEL levels than both 
the liver and muscle tissues for all treatments.  Also all the treatments within the kidney group 
differed significantly (P < 0.01).  The results for MEL50 and MEL100 in the liver and muscle did not 
differ from each other, but a difference (P < 0.05) was observed between muscle and liver tissue for 
MEL500.  The MEL distribution level increased in all tissues for each treatment as the concentration 
increased (Figure 6). 
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Figure 6  An illustration of the relationship between the distribution of melamine (mg/kg) in muscle, 
liver and kidney tissue on Day 36.  a-eMeans with different superscripts differed significantly (P < 
0.05).  Treatments:  1 = no added melamine; 2 = dietary melamine 50 mg/kg; 3 = dietary melamine 
100 mg/kg; 4 = dietary melamine 500mg/kg; 5 = dietary cyromazine 4 mg/kg. 
 
3.3.4. Distribution efficiency rate 
 
The distribution efficiency (DEf) of MEL to muscle tissue was calculated as follows: 
 
DEf (%) = MEL residues (mg) in total muscle mass tissue / MEL intake (mg) per day 
 
The chemical analyses were done on dried tissue samples and the results were converted back to a wet 
basis.  The average moisture content of the lean muscle samples was 738 g/kg.  For total muscle mass 
determination, it was assumed that the total average lean muscle content of the whole bird was 62 % 
(Lin et al., 2001).  Because only the Pectoralis major and minor muscle groups were sampled in the 
current trial, it was further assumed that MEL was distributed equally to all the muscle groups.  
Calculations were also based on the assumption of a seven day depletion rate of MEL from muscle 
tissue (Lü et al., 2009a and Bai et al., 2010).  Results are presented in Table 11 and Figure 7. 
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Table 11  The distribution efficiency (%) of melamine to muscle tissue in broilers receiving different 
levels of dietary melamine. 
 Day 
Treatment1 18 22 29 36 
2 1.749ab,x 2.659c,x 1.727b,xy 1.294a,y 
3 1.447ab,xy 2.223c,xy 2.028b,x 1.238a,y 
4 1.263ab,y 2.048c,y 1.370b,y 1.274a,y 
Pooled SEM2 0.093 0.141 0.176 0.081 
1Treatments:  1 = no added melamine; 2 = dietary melamine 50 mg/kg; 3 = dietary melamine 100 mg/kg; 4 = dietary melamine 500   
 mg/kg; 5 = dietary cyromazine 4 mg/kg. 
2Pooled standard error means. 
a-cMeans within rows with different superscripts differed significantly (P < 0.05). 
x-yMeans within columns with different superscripts differed significantly (P < 0.05). 
 
 
 
 
Figure 7  An illustration of the mean distribution efficiency (%) values of the total melamine 
deposited in the whole bird.  Treatments:  1 = no added melamine; 2 = dietary melamine 50 mg/kg; 3 
= dietary melamine 100 mg/kg; 4 = dietary melamine 500mg/kg; 5 = dietary cyromazine 4 mg/kg. 
 
 
It was apparent that there was a definite pattern for DEf to increase as the concentration MEL 
decreases.  A significant difference (P < 0.01) was found between Day 22 and the other days.  Day 29 
also differed significantly (P < 0.05) from Days 22 and 36.   
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3.4. Discussion 
 
3.4.1. Production parameters 
 
In this study, no differences in feed intake, body weight gain and FCR were found between treatment 
groups that received graded levels of MEL and the control group (CYR4 will be discussed in the next 
paragraph).  According to Ledoux et al. (2009) the effect of MEL ingestion on feed intake, body 
weight gain and FCR was mainly observed after ingested MEL levels of 1000 mg/kg was provided, 
after which a decrease in these production parameters could be observed.  A further decrease can be 
expected if the MEL content of feed increased to levels of 1000 mg/kg and above.  For broilers (Lü et 
al., 2009a) and ducks (Lü et al., 2009b) it was reported that feed intake, body weight gain and FCR 
was not suppressed in birds receiving feed containing 1000 mg/kg MEL and mortalities only 
increased after 1500 mg/kg.  Therefore, it seems as if broilers can tolerate MEL levels up to 1000 
mg/kg without adversely affecting feed intake, body weight, FCR and mortality.   Since the highest 
inclusion level in the current study was only 500 mg/kg, these results are in accordance with Ledoux 
et al. (2009) and Lü et al. (2009a). 
 
Even though no differences in feed intake, body weight gain and FCR between MEL50, MEL100 and 
MEL500 are being reported, CYR4 differed significantly (P < 0.01) from the other treatments (Figure 
4) with superior feed intake and FCR (P < 0.05).  Related literature reported no differences in feed 
intake after including 1000 mg/kg Larvadex® in the diet (Cecil et al., 1981; Wilson et al., 1983; Brake 
et al., 1984; Brake et al., 1985 and Brake et al., 1989) with a rapid decrease after 1000 mg/kg which 
contradicts these results, where 400 mg/kg resulted in a significant increase (P < 0.01) in feed intake.  
The reason for the increased feed intake due to CYR ingestion is unknown.  Other researchers did 
report an improved FCR, but it was based on the fact that a decrease intake improved feed utilization.  
Body weight was not affected by CYR since CYR4 did not differ from the other treatments.  These 
findings are similar to the authors mentioned in this paragraph who did not find any changes in body 
weight for birds receiving Larvadex® up to 1000 mg/kg. 
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The study of Kidd et al. (1996) has shown that feed protein was better utilized in low protein diets and 
that higher protein efficiency percentages indicate more efficient utilization.  Kidd et al. (1996) fed a 
diet containing a crude protein level of (16.8%) to broiler chicks and reported protein efficiency 
values of 2.46-2.86%.  In the current study, diets containing 19.26% crude protein were fed during the 
finisher phase and it was found that MEL50, MEL100 and MEL500 had similar values (2.859%, 
2.768% and 2.817% respectively) as presented by Kidd et al. (1996), which further supports the 
findings of Kidd et al. (1996) that the increased dietary crude protein had lower utilization compared 
to diets containing less crude protein.  However, the MEL included in the test diets could have 
contributed to the poorer performance.  In fact, the protein efficiency values of CYR4 (3.403%) and 
CON (2.968%) contradicted the findings of Kidd et al. (1996).  An obvious explanation would be that 
improved genetic selection for production parameters over the past 15 year has been achieved and 
therefore the difference between Kidd et al. (1996) and the present study.   
 
Considering the EPEF (Table 8), no difference occurred between treatments and all values were above 
310.  In the industry a value above 300 could be considered as a fine achievement and therefore it 
seems as if the inclusion of MEL up to 500 mg/kg did not influence overall performance and that a 
CYR inclusion also had a tendency to improve performance. 
 
3.4.2. Melamine concentration in muscle tissue 
 
Following the inclusion of graded levels of MEL in three broiler diets on Day 9, detectable MEL 
levels were already observed on Day 11 in the breast muscle for MEL50, MEL100 and MEL500.  No 
differences were observed between MEL50 and MEL100 throughout the trial, but MEL500 resulted in 
higher concentration of MEL residues in muscle.  This is in accordance with results reported by Lü et 
al. (2009a), Bai, et al. (2010) and Yuchang et al. (2010), who found that MEL increased.  The muscle 
MEL concentrations of MEL500 on Days 15 and Day 18 obscured the general pattern, but it would 
appear that MEL residue levels reached a maximum value on Day 22 and then decreased towards Day 
36 of the trial.  It could be mentioned that the birds of MEL500 that were executed on Day 15 had 
enlarged gallbladders which were almost twice the size of the other treatment groups.  This might 
indicate some disturbance in digestion that, by speculation, could have caused reduced MEL 
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absorption and resulted in the lower MEL values that were observed on Days 15 and 18.  The decrease 
in MEL concentration that had been observed after Day 22 might indicate a possible metabolic 
response that develops over time and which enabled the birds to clear MEL residues from the muscle 
more efficiently.  A similar observation was reported by Lü et al. (2009a) and they speculated that 
broilers may develop an advanced capacity to clear MEL from the body with increasing age. 
 
Lü et al. (2009a) reported that MEL was undetectable in meat samples within seven days after 
withdrawal of MEL from the feed, and Bai et al. (2010) detected a very low level of 0.0025 mg/kg 
MEL in meat 10 days after withdrawal.  Yuchang et al. (2010) reported that a single feeding of feed 
that contained 100 mg/kg of MEL was eliminated within 24 hours in chicken and duck meat and up to 
96 hours in other animal species, except for fish (up to 14 days).  In the current study, no MEL 
residues could be detected in muscle tissue after a seven day withdrawal period.  It might have been 
more useful to determine the MEL residues in meat within a shorter withdrawal period (i.e. 1 or 2 
days after withdrawal) instead of 7, 14 and 18 days.  Nevertheless, the results were comparable to that 
of Lü et al. (2009a) and therefore supporting the fact that MEL concentrations of < 0.05 mg/kg (if 
any) might be present in poultry meat after a withdrawal time of 7 days, but that such low levels are of 
no concern for human consumption.  
 
No MEL could be detected in the meat samples of CYR4 and similar results were reported by Boon et 
al. (1985).  Many reports discussing the detection of CYR in meat samples after ingesting a diet 
containing CYR are available; however, very few reports are available that report on the distribution 
of MEL in meat due to the inclusion of CYR in the diet.  It has been reported that 10% of ingested 
CYR is metabolizable to MEL (US EPA, 2007).  In the current study 4 mg/kg CYR was applied to 
CYR4 and therefore, theoretically 0.4 mg/kg MEL could have been metabolized to MEL.  Based on 
the results of MEL50, which resulted in a muscle MEL concentration of 7.13 mg/kg (Table 9), and 
assuming a similar distribution efficiency, it was calculated that 0.4 mg/kg MEL originating from the 
metabolization of 4 mg/kg CYR, would theoretically yield a residue concentration of 0.057 mg/kg.  If 
the current tolerable daily intake for humans is 0.2 mg/kg body weight (WHO, 2008), any possible 
MEL residues in broiler muscles resulting from CYR metabolization are no reason for concern.  
Therefore, if the current recommendations for the application of the CYR product Larvadex® (1% 
premix) in poultry feed are followed, muscle MEL residues should be well within tolerable limits.  
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3.4.3. Melamine concentrations in liver and kidneys 
 
From the results, it is evident that the kidneys contained a significantly higher (P < 0.01) 
concentration of MEL, followed by muscle and liver tissues (Figure 6).  It was once again evident that 
an increase in the MEL dietary level resulted in an increased MEL distribution to all tissues.  Similar 
findings were reported by Lü et al. (2009a), Bai et al. (2010) and Yuchang et al. (2010) where the 
kidney had higher residual levels confirming the findings that there is a difference between the 
distribution patterns of MEL to different body tissues.  Even though it was not statistically significant, 
muscle tissues were found to contain slightly more MEL than the liver.  Lü et al. (2009a) and Bai et 
al. (2010), on the other hand, reported definite findings that the MEL concentration was higher in the 
liver than the muscle tissue.  No MEL from CYR could be detected in any of the tissue samples.   
 
3.4.4. Distribution efficiency (DEf) 
 
Other relevant studies (Lü et al., 2009a; Bai, et al., 2010 and Yuchang et al., 2010) reported the 
distribution of MEL into muscle tissue as a ratio of the concentration MEL in the feed.  However, 
these finding do not take into account the actual amount of MEL ingested that is retained in the 
muscle.  Therefore, the method used by Cruywagen et al. (2010) was followed where the MEL values 
obtained are expressed as a fraction of the MEL ingested.  A retention time of 7 days was used as 
reported by Lü et al. (2009).  In the current study, the DEf of MEL to meat was 1.3 to 2.7%.  
Cruywagen et al. (2009) reported an efficiency value of 2.1% in milk and 3.6% in muscle tissue of 
Merino sheep (Cruywagen et al., 2010).  
 
From Figure 7 it can be seen that the treatment with the lowest MEL content (MEL50) resulted in the 
highest efficiency rate, suggesting that lower dietary MEL levels would be distributed to meat more 
efficiently than higher levels.  Kidd et al. (1996) observed similar tendencies for protein utilization.  
In the current study a significant increase (P < 0.05) in efficiency rates was observed for Day 22 in all 
treatments, followed by an even decrease in Days 29 and 36.  It could probably be ascribed to the 
rapid muscle growth rate from around Day 20 and thus also explaining the reason for the higher value 
in MEL100 on Day 29 since a slight increased growth rate was observed for this group.  
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According to the results, it is calculated that, if a 36 day old broiler is fed a diet containing 100 mg/kg 
MEL and consumes 168 mg/kg feed a day, the total MEL deposited in the muscle fraction of the 
whole chicken would contain 1.456 mg MEL.  These values are within the detection limit of 2.5 
mg/kg (Setiogi, 2008) that are allowed for food.  However broiler diets containing 500 mg/kg MEL 
revealed values of 7.493 mg/kg and therefore MEL inclusions in broiler diets above 100 mg/kg should 
be avoided to ensure that MEL concentration levels are below the legal limit for food. 
 
3.5. Conclusion 
 
The current trial showed that dietary MEL levels of up to 500 mg/kg did not have an effect on 
production parameters.  It has been confirmed that MEL could be distributed to breast meat within 
two days after chickens had ingested MEL tainted diets.  As the dietary MEL concentration increased 
from 50 and 100 mg/kg to 500 mg/kg, a significant increase was observed in tissue MEL residue 
concentrations.  A peak MEL concentration was observed at 22 days of age for all treatments, 
followed by a decrease until day of slaughter, which might indicate that broilers developed an 
enhanced capacity with advancing age to clear MEL from their system.   After a seven day withdrawal 
time, no more MEL could be detected in meat samples.  As expected, the kidneys contained the 
highest MEL residue levels, followed by the muscle and liver tissues.  Furthermore, no MEL could be 
detected in meat samples of broilers subjected to a diet containing 4 mg/kg CYR.  Finally, distribution 
efficiencies of MEL to meat were determined and these values were comparable to those reported for 
other species (Merino L. dorsi) and products (Holstein milk). 
 
The illegal MEL contamination of food products will surely persist until such products can be banned 
from every country; however, the realization of this suggestion is unlikely.  Even though doctors and 
veterinarians agree that no MEL should be included in food products for human and animal 
consumption, tolerable daily intake levels have been implemented in an attempt to control MEL 
adulteration.  Therefore, the current study is considered to be relevant and was intended to provide 
knowledge on the inclusion of MEL in poultry feed.   For future studies it might be useful to harvest 
meat samples earlier than two days after exposure to determine how fast MEL would occur in meat 
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samples.  However, birds should preferably not be younger than 10 days, since the harvested samples 
might be too small to analyze.  Also, it would be interesting to determine if any detectable MEL 
residues are still present in meat within a shorter withdrawal period than seven days to set an accurate 
withdrawal period if commercial birds have accidentally been fed a diet containing MEL 
contaminated raw materials.  This will also be useful to determine a more accurate DEf. 
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4. CHAPTER 4                                                                         
Absorption of dietary melamine and cyromazine and subsequent distribution to 
poultry eggs 
 
4.1. Introduction 
 
In the year 2006, hundreds of pets have fallen ill (WHO, 2008) due to unknown reasons after 
consuming certain brands of pet food.  The problem was soon identified to be caused by the presence 
of the industrial chemical melamine (MEL).  Then in 2008, after it was confirmed once again that 
MEL was the main contaminant in infant formula, causing renal failure in thousands of infants, global 
attention was focussed on this substance and its inclusion in consumer food products (WHO, 2008).  
In the industry MEL (C3H6N6) or 1,3,5-triazine-2-4-6 triamine, has various applications and is 
primarily known for its use in plastic ware (China Chemical Reporter, 2006).  Since MEL has a 
nitrogen content of 670 g/kg on a molecular weight basis (Merck, 2001), it has been included in food 
products (especially animal feeds) with a deceptive purpose to increase the apparent crude protein 
level of feed (AOAC, 2000).     
 
The major illness effect of MEL is renal failure due to crystal formation in the proximal tubules, 
effectively causing blockage (Kobayashi et al., 2010).  In the poultry layer industry hens are 
productive until approximately 72 weeks of age and therefore the effect of renal complications can 
have a major influence on overall performance efficiency.  Melamine is also an intermediate 
compound of cyromazine (CYR) metabolism in the animal.  Cyromazine is the active ingredient of 
some pesticides, such as Larvadex ®, which is commonly added to poultry layer feed to control flies 
(Sancho et al., 2005).  Larvadex® can conveniently be added to layer diets after which it is passed in 
the faeces where the fly eggs are laid.   Therefore, by including products that contain CYR in layer 
feed, MEL could potentially occur in eggs even though no MEL has been added to the feed.  
 
Relevant literature on the current study field is limited to only a handful of contributing authors (Lu et 
al., 2009; Bai et al., 2010; Chen et al., 2010; MAFF, 2010 and Yuchang  et al., 2010).  Two similar 
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studies have also been executed on layer ducks (Gao et al., 2010 and Yuchang  et al., 2010) and 
definite MEL deposition tendencies exists for the two layer species as will be discussed later.  
However, further research would be beneficial to enhance the reliability of the reported results to 
provide more accurate and consistent technical support to the industry regarding this matter. 
 
It has been reported that over 17 million cases of eggs have been produced during 2009 in South 
Africa (Vauqulin, 2010).  Poultry and duck eggs are used in a wide variety of food products which 
means that the majority of the global population could potentially be exposed to MEL contaminated 
eggs.  As a result, it is important to establish the distribution rate of MEL to eggs after ingesting 
contaminated feed, emphasising the necessity of the current study.  The objectives of the current study 
were: 
1. to determine the distribution efficiency of MEL from feed to eggs when MEL was added to 
layer diets at different levels, ranging from 0 to 500 mg/kg. 
2. to determine if a MEL withdrawal period would result in eggs with non-detectable levels of 
MEL and how long it would take 
3. to determine if CYR in the feed would result in MEL being detected in eggs had been 
withdrawn 
4. to determine if dietary MEL and CYR would have an effect on layer production. 
 
4.2. Materials and methods 
 
All harvesting methods were practised strictly according to the ethical requirements that have been 
approved by Subcommittee B of the University of Stellenbosch (Reference # 2008B03003).  The 
Larvadex® product contains 99% inert products and only 1% CYR (Drugs.com, 2010).  Since it was 
recommended by the suppliers that Larvadex® should be included at 400 mg/kg, CYR4 therefore 
effectively received 4 mg/kg CYR which is below the maximum legal level of 5 mg/kg (Drugs.com, 
2010). 
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4.2.1. Birds, housing and management 
 
One hundred and twenty Hyline Silver hens (24 weeks of age), provided by the Mariendahl Poultry 
unit from the University of Stellenbosch, were relocated for trial purposes from a commercial unit to 
an experimental house.  At the end of the trials, all participating hens were euthanized according to the 
ethical protocol.  The trial was conducted during the summer months and hens were allowed three 
days to adapt to their new surroundings.  The birds were exposed to a similar housing system (open 
houses and natural ventilation with sprayers on the roof for additional cooling) and received the same 
diet, lighting regime (16 hours light and eight hours darkness) and climate control than what they were 
accustomed to.  Four hens were allocated per cage and six cages per treatment were used. 
 
4.2.2. Treatments and experimental diets 
 
1. Treatment 1 (CON) received a diet containing no detectable levels of MEL or CYR.  
2. Treatment 2 (MEL50) received a diet containing 50 mg/kg MEL and no CYR. 
3. Treatment 3 (MEL100) received a diet containing 100 mg/kg MEL and no CYR. 
4. Treatment 4 (MEL500) received a diet containing 500 mg/kg MEL and no CYR. 
5. Treatment 5 (CYR4) received a diet containing 4 mg/kg CYR and no MEL.  
 
Diets were mixed on the Mariendahl Experimental Farm of the Stellenbosch University.  Maize gluten 
meal imported from China found to be an adulterated product (Cruywagen & Reyers, 2009), was used 
as one of the MEL sources in the diets.  The MEL content of the product was 15 117 mg/kg.  It also 
contained urea, wheat bran, maize bran, gluten 20 and actually very little gluten 60.  Because of the 
nature of the product it was thus decided to limit the inclusion level thereof and to balance the 
required MEL content of the diets with pure MEL (Sigma-Aldrich M2659, Supplied by Sigma, Cape 
Town).  The minor ingredients were carefully weighed out and mixed in an industrial blender with a 
10 kg capacity.  The mixture was then transferred to a horizontal ribbon mixer (100 kg capacity) 
where the major ingredients were then added.  First, the CON treatment diet was mixed followed by 
the CYR4, MEL50, MEL100 and lastly the MEL500 diet to avoid contamination between diets.  All 
feeds were presented as a meal and stored in a cool dry area in 50 kg bags.  At the end of Day 3, just 
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before the lights went out, the five diets were made available to the hens.  The experimental diets were 
offered to the hens until Day 10 after which they all received a control diet.  The formulations and 
calculated nutritive analysis for the five different diets are presented in Table 12. 
 
Table 12  The composition and calculated analysis (g/100g as fed) of layer treatment diets. 
  Layer treatment1diet 
Item 1 2 3 4 5 
Ingredient      
   Maize Gluten 602  - 0.33 0.67 3.33 -  
   Melamine3 0.00 0.005 0.01 0.05 0.00 
   Larvadex - - - - 0.04 
   Vit+Mineral Mix4 0.15 0.15 0.15 0.15 0.15 
   Maize 52.3 44.9 52.0 51.2 48.9 
   Wheat Bran - 6.84 - - - 
   Soybean Full Fat 25.2 34.8 24.7 22.6 29.2 
   Soybean 46 9.33 - 9.42 9.79 - 
   Sunflower - - - - 8.65 
   L-lysine HCl 0.06 0.08 0.07 0.08 0.15 
   DL-methionine 0.19 0.19 0.18 0.15 0.17 
   Limestone 10.6 10.7 10.6 10.6 10.6 
   Salt 0.27 0.28 0.27 0.26 0.25 
   Monocalcium Phosphate 1.68 1.54 1.68 1.68 1.66 
   Sodium Bicarbonate 0.29 0.27 0.29 0.29 0.29 
Calculated Analysis      
   AMEn5 (MJ/kg) 11.50 11.50 11.50 11.50 11.50 
   Crude Protein 18.28 18.28 18.28 18.28 18.28 
   Calcium 4.20 4.20 4.20 4.20 4.20 
   Total phosphorus 0.77 0.77 0.77 0.77 0.77 
   Available phosphorus 0.50 0.50 0.50 0.50 0.50 
   Digestible lysine 0.94 0.94 0.94 0.94 0.94 
   Digestible methionine 0.44 0.44 0.44 0.44 0.44 
   Digestible threonine 0.60 0.60 0.60 0.60 0.60 
1Treatments:  1 = no added melamine; 2 = dietary melamine 50 mg/kg; 3 = dietary melamine 100 mg/kg; 4 = dietary melamine 500 
mg/kg; 5 = dietary cyromazine 4 mg/kg. 
2The maize gluten 60 contained melamine at a level of 15117 mg/kg. 
3Melamine powder (Sigma-Aldrich M2659, Supplied by Sigma, Cape Town). 
4Vitamin+mineral premix provided (per kg of diet): 8160 IU vitamin A, 1700 IU vitamin D3, 30.6 IU vitamin E, 2.7 mg vitamin K3, 
2.05 mg vitamin B1, 2.05 mg vitamin B2, 27.2 mg niacin, 10.2 mg calcium pantothenate, 0.02 mg vitamin B12, 4.1 mg vitamin B6, 1.7 
mg folic acid, 0.068 mg biotin, 120 mg ronozyme p500, 350 mg choline, 0.08 mg I, 0.34 mg Co, 0.2 mg Se, 70 mg Mn, 70 mg Zn, 6 mg 
C and 50 mg Fe. 
5AMEn = Apparent metabolizable energy. 
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Samples of all experimental diets were analysed to determine the true MEL inclusion levels by using 
the LC-MS/MS method (Table 13).  Samples (100 g) were milled with a 1 mm screen prior to 
evaluation. 
 
Table 13  The expected and analyzed values (mg/kg) of the melamine diets for trial purposes. 
Treatment1 Expected values Analyzed values 
1 0 ND 
2 50 56.50 
3 100 130.8 
4 500 531.7 
5 0 1.971 
1Treatments:  1 = no added melamine; 2 = dietary melamine 50 mg/kg; 3 = dietary melamine 100 mg/kg; 4 = dietary melamine 500 
mg/kg; 5 = dietary cyromazine 4 mg/kg. 
 
The MEL50, MEL100 and MEL500 birds received the diets as described above from Days 1-10 to 
determine if dietary MEL would result in MEL residues in the eggs and to determine the distribution 
efficiency.  As from Days 11-20, MEL 50, MEL 100 and MEL 500 groups were switched back to a 
control diet identical to the diet fed to the CON treatment to determine if a MEL withdrawal period 
would result in eggs with non-detectable levels of MEL. 
 
Hens in CYR4 received a diet containing Larvadex, as mentioned above, and were compared to the 
CON treatment.  The justification for the CYR4 group was to determine if MEL (derived from the 
metabolism of CYR, the active ingredient in Larvadex) was distributed to eggs and to determine the 
efficiency of the distribution.  The rate of depletion in the absence of Larvadex was not tested, since 
previous trials conducted by the University revealed low distribution rates in the first instance.  
Therefore, CYR4 received the Larvadex diet for Days 1-20. 
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4.2.3. Measurements and sampling 
 
The trial was conducted during the summer months and temperature readings were recorded daily to 
explain possible changes for feeding patterns.  All birds were weighed prior to the experimental 
initiation and again on the last day of the experimental period (20 days).  Feed intake was measured 
for each cage separately throughout the duration of the trial.  Mortality and morbidity were monitored 
and reported daily.  Eggs were collected once every day at the same time; weighed individually and 
then marked with a pencil to indicate the date, weight, cage and treatment number.  One cage’s eggs 
represented one experimental unit to account for birds who would skip a day.  The collected eggs 
were stored below 25°C for 28 days until relocation to a cold room (4°C) for 1-9 days prior to the 
beginning of laboratory analysis.   
 
4.2.4. Laboratory analyses 
 
All the eggs were individually weighed again and the egg contents were cracked into a polypropylene 
jar, previously tared on a scale and the weight of each egg was recorded in this manner.  The reason 
why the eggs were weighed again prior to breakage was to determine moisture loss from the fresh 
eggs until sample processing for consumer purposes.  The egg contents were individually 
homogenized with a Polytron (Patent–Lizenz Prof. P. Willems, Luzern Kinematisches Hochfrequenz 
– Gerät, Type: PT45/50 OD no. 4860, Volt 220, Amp 5, Hz 50)  and poured into marked plastic bags.  
One egg from each cage of MEL500 (collected on Day 10) was separated to estimate MEL 
distribution ratio to the albumin and yolk and were treated the same as the whole egg samples.   The 
bagged samples were stored at -18°C until further laboratory analyses commenced. 
 
Eggs collected on Days 1, 2, 3, 4, 5, 7, 10, 11, 12, 14 and 16 were selected to be analyzed for MEL 
detection.  The eggs collected for each cage were pooled together to represent an experimental unit 
and were homogenized once again to establish an even mixture.  The following chemicals, equipment 
and sample preparations (as described by Xia et al., 2009) were necessary before the LC-MS/MS 
analysis: 
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Chemicals and Reagents: 
− Egg sample (2 g) 
− 5% Trichloroacetic acid 
− Methanol (12 mL) 
− Water (6 mL) 
− 100 µL of a 0.5 mg/L stable isotope labelled MEL (13C3H615N3) internal standard solution 
(Cambridge Isotope Laboratories, Inc., Andover, MA). 
− 0.1N HCl (6 mL) 
− 6 mL ammonium hydroxide:methanol:dichloromethane (1:5:5) 
− 1 mL acetonitrile (50%) 
− Nitrogen 
 
Other Consumables and Equipment: 
− Scale (Mettler AE 160) 
− Micro pipette (5 mL) 
− 5 mL Pipette tips 
− Vortex (Heidolph, Batch no: 10834, 230 V ~ 50 Hz, 30 Watt, U/min 200-2400, Made in 
West Germany) 
− Tubes (15 mL polypropylene and 15 mL glass) 
− Centrifuge (Sigma Laborzentrifugen, D-37520 Ost-rode am Harz, Germany, Type Model 
2-16K, Fabrik no: 112234, V/Hz 230/50  1 Ph, 720 Watt) 
− Ultrasonic bath 
− Cation exchange solid phase extraction (SPE) cartridges (Phenonenex Strata SCX, 55 µm, 
70 A, 500 mg/3 mL, supplied by Separations, Randburg, South Africa) 
− Waters API Quattro Micro triple quadruple mass spectrometer 
− Waters 2690 HPLC (Waters Corporation, Milford, MA).    
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Sample Preparation: 
− A representative sample (2 g) was collected from each mixture and transferred to a 20 mL 
tube. 
− 5% Trichloroacetic acid (10 mL) was added and the mixture was vortexed for one minute. 
− The mixture was then centrifuged (4°C) at 8603 x g for 10 minutes. 
− The supernatant (5 mL) was transferred to clean marked tubes and frozen at -18°C.  
 
Method: 
− Condition the cation exchange SPE cartridges with 6 mL methanol followed by 6 mL 
water. 
− Load the supernatant of the extracts (5 mL) and 100µL of a 0.5 mg/L stable isotope–
labelled MEL (13C3H615N3) internal standard solution onto the SPE cartridges.  Therefore, 
0.05µg MEL is loaded onto each cartridge.  
− Wash the cartridges with 6 mL of 0.1 N HCL and subsequently with 6 mL methanol while 
aspirated under vacuum for one minute. 
− Elute the MEL with 6 mL ammonium hydroxid:methanol:dichloromethane (1:5:5) into a 
clean tube. 
− Dry the extracts under a nitrogen stream and resuspend it in 1 mL of 50% acetonitrile. 
− Analyse the samples with liquid chromatography–tandem mass spectrometry (LC–
MS/MS) on the Waters API Quattro Micro triple quadruple mass spectrometer, coupled to 
a Water 2690 high performance liquid chromatographer (HPLC).  
− For egg samples, the detection limit of this method is 0.01 mg/kg. 
− Use the internal standard to correct for possible incomplete extractions. 
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4.2.5. Statistical analyses 
 
All of the production data were subjected to a two-way analysis of variance (ANOVA) using the 
general linear models (GLM) procedure and were analysis with the Statistica Version 9 (2010) 
package.  The repeated measure of analysis method was conducted on the MEL concentrations data.  
Mixed models were used to compare distributed MEL concentrations in the yolk, albumin and whole 
egg and a one-way ANOVA to calculate differences between the distribution efficiency rates.    
 
4.3. Results 
 
4.3.1. Production parameters 
 
The trial was conducted during the summer months and environmental temperature had a definite 
effect on body weight and feed intake.  Maximum temperatures fluctuated between 27-40°C and night 
temperatures were 13-22°C while most of the temperature readings above 35°C were recorded during 
the last five days of the trial.  All treatment groups lost between 2-5% of their total body weight 
during the 20 day study.  Results are reported in Table 14.    
 
Table 14  The average body weight (kg) measured1 for treatments on the first and last day of the trial. 
 Day  
Treatment 1 20 P   
1 7.8a 7.4b 0.05 
2 7.8a 7.4b 0.05 
3 7.6a 7.4b 0.05 
4 7.7a 7.5b 0.05 
5 7.9a 7.5b 0.05 
1Mean body weight of six cages. 
a-dMeans with different superscripts differed significantly (P < 0.05). 
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No differences were found between treatments; however, weight on Day 1 differed significantly (P < 
0.05) from weights on Day 20.  The greatest weight loss (5%) was reported for CON and CYR4 while 
MEL100 and MEL500 only lost 2% of their body weight. 
 
Feed intake for all treatments declined during the last 10 days of the trial and could be contributed to 
the high ambient temperatures.  No interaction between treatments and days were found; however, the 
treatments (P < 0.05) as well as the days (P < 0.01) differed significantly from each other (Table 15).   
 
Table 15  The average feed intake (kg) of an experimental unit during the first and second stage of the 
trial.  Layer hens were subjected to graded levels of melamine as well as cyromazine over a period of 
20 days. 
 Day 
Treatment 1-10 11-20 
1  4.3a,x 3.4b,x 
2 4.5a,xy 3.6b,xy 
3 4.7a,y 3.6b,y 
4 4.2a,x 3.5b,x 
5 4.6a,y 3.6b,y 
a-bMeans in a row with different superscripts differed significantly (P < 0.01). 
 x-yMeans in a column with different superscripts differed significantly (P < 0.05). 
 
It is evident from Table 15 that hens in MEL100 and CYR4 consumed the most feed during the first 
10 days of the study.  There was a significant difference (P < 0.01) between Days 10 and 20 where all 
the treatments showed a decrease in feed intake over time. From all of these findings it is probable 
that the high environmental temperatures suppressed feed intake and body weights during the last 10 
days of the trial. 
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Table 16  The total daily egg production for treatments over a 20 day trial. 
 Day  
1Treatment 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Total
1 21 23 23 23 24 24 24 24 24 22 23 23 23 23 23 23 22 23 22 22 459a
2 24 23 20 23 23 22 23 23 23 23 23 23 23 23 22 22 21 23 23 23 453a 
3 24 23 22 22 23 24 24 24 24 24 23 24 24 23 24 24 23 22 22 23 466a 
4 24 23 22 24 24 24 24 24 24 21 24 23 21 22 20 22 22 21 22 21 452a 
5 20 22 23 20 22 21 21 21 21 21 21 21 20 21 21 21 20 19 20 19 415b 
Total 113 114 110 112 116 115 112 116 112 111 114 114 111 112 110 112 108 108 109 108  
1Treatments:  1 = no added melamine; 2 = dietary melamine 50 mg/kg; 3 = dietary melamine 100 mg/kg; 4 = dietary melamine 500   
  mg/kg; 5 = dietary cyromazine 4 mg/kg. 
 a-bMeans in a column with different superscripts differed significantly (P < 0.01). 
 
 
Table 17  The average egg weight (g) for each treatment over the 20 day trial period. 
 Day  
Treatment 1-5 6-10 11-15 16-20 Average 
1 52.8abc,uv 52.7abcde,uv 53.2defg,vw 53.7efg,wx 53.1 
2 52.9abc,uv 53.3abcde,vw 53.8defg,wx 55.0efg,z 53.7 
3 51.6abc,t 52.8abcde,uv 53.7defg,wx 53.9efg,wx 53.0 
4 51.2abc,t 52.5abcde,uv 53.2defg,vw 53.1efg,vw 52.5 
5 50.5abc,s 53.1abcde,vw 54.0defg,xy 54.8efg,yz 53.1 
1Trt = Treatments:  1 = no added melamine; 2 = dietary melamine 50 mg/kg; 3 = dietary melamine 100 mg/kg; 4 = dietary melamine 500mg/kg; 5 = dietary cyromazine 4 
mg/kg. 
a-gMeans in a row with different superscripts differed significantly (P < 0.05). 
s-zMeans in a column with different superscripts differed significantly (P < 0.05). 
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Only two birds died (CON and MEL 500) during the whole study while one hen was morbid 
(MEL50) and was removed from the trial.   Regarding egg production, no differences were found over 
time.  There was, however, a tendency for production to decrease from Day 8 to Day 20 (Table 16).  
A significant difference (P < 0.01) was found between treatments and throughout the trial CYR4 
produced the least number of eggs, while egg production did not differ between CON, MEL50, 
MEL100 and MEL500.   Egg weight differed between treatments (P < 0.05), as well as between days 
(P < 0.05) (Figure 8).  MEL500 had the lowest average egg weight compared to CON, MEL50, 
MEL100 and CYR4 (Table 17).  There seemed to be an increase in egg weight during the trial. 
 
 
Figure 8  The mean egg weight (g) of each treatment combined to illustrate the effect of time (day) on 
egg weight.  a-gMeans with different superscripts differed significantly (P < 0.05). 
 
As a slight decrease in egg number over time was observed, the tendency for egg weight to increase 
with time as revealed in Figure 8 seems sensible.    Egg weight content was also measured and it 
attributed 86% of the total egg weight for all treatments. 
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4.3.2. Melamine concentrations in eggs 
 
The data that were collected for the MEL concentrations in the eggs are displayed in Table 18.  Days 
1, 2, 3, 4, 5, 7 and 10 were tested to determine the manner of MEL distribution and Days 11, 12, 14 
and 16 were evaluated to establish a withdrawal rate after MEL ingestion.  From the statistical 
analyses there appeared to be significant interaction (P < 0.01) between the treatments and days.  In 
Figure 9  it is clear that MEL was deposited in eggs within 24 hours after ingestion.  There was an 
increasing trend for MEL distribution in eggs as the dietary MEL content increased.   
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Table 18  The concentration of melamine (mg/kg dry weight) in layer eggs after feeding diets containing graded levels of melamine over 
time. 
 Day 
Treatment1 1 2 3 4 5 7 10 11 12 14 16 
1 ND2 ND ND ND ND ND ND ND ND ND ND 
2 4.4 ± 0.53 1.4 ± 0.8 2.7 ±1.0 2.8 ± 1.5 1.8 ± 0.8 1.5 ± 0.2 0.8 ± 0.4 0.9 ± 0.3 0.1 ± 0.02 0.1 ± 0.02 0.04 ± 0.02 
3 4.5 ± 0.9 2.4 ± 0.7 2.9 ± 0.6 3.7 ± 0.5 2.2 ± 1.3 3.2 ± 0.5 2.3 ± 1.2 2.6 ± 0.5 0.5 ± 0.08 1.0 ± 0.1 0.02 ± 0.01 
4 3.1 ± 1.2 16.3 ± 9.4 14.7 ± 2.3 16.7 ± 2.8 13.1 ± 2.4 12.9 ± 1.4 9.0 ± 2.9 4.3 ± 3.9 0.9 ± 4.1 0.3 ± 0.04 0.04 ± 0.01 
1Treatments:  1 = no added melamine; 2 = dietary melamine 50 mg/kg; 3 = dietary melamine 100 mg/kg; 4 = dietary melamine 500 mg/kg; 5 = dietary cyromazine 4 mg/kg. 
2Not detected. 
3Data are displayed as means ± SD (n = 6).  
 
 
 
 
Figure 9  An illustration of the mean concentrations (mg/kg) of melamine in eggs after ingesting diets containing graded levels of melamine 
over time (day). 
Melamine withdrawal 
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From Figure 9, MEL500 differed significantly (P < 0.05) from MEL50 and MEL100 except for Days 
1, 12, 14 and 16.  The major differences between MEL50 and MEL100 occurred on Days 12, 14 and 
16.  It seems as if MEL levels peaked between Day 1 and Day 4 and then slowly decreased until Day 
10.  The residual concentration of MEL rapidly decreased after the withdrawal period was initiation at 
the end of Day 10.  On Day 16, MEL levels for all treatments were below 0.05 mg/kg.  No MEL could 
be detected as a result of CYR ingestion and therefore no statistical analysis was performed on the 
latter. 
 
4.3.3. A comparison of the melamine concentrations detected in albumin, yolk and whole egg 
 
No differences were found between treatments regarding MEL concentration in albumin (9.586 
mg/kg), yolk (7.710 mg/kg) and whole egg (8.460 mg/kg).   
 
4.3.4. Distribution efficiency rate (DEf) 
 
A DEf of MEL to eggs was established by applying the following calculation: 
 
 Distribution efficiency (%) = MEL residues (mg) in total egg / MEL intake (mg) per day 
 
Results were calculated on an as is basis since the MEL concentration results were determined on a 
similar basis, as well as egg content measurements.  To calculate the MEL distributed to the total egg, 
the weight (kg) of the whole egg (without the shell) were multiplied with the detected MEL 
concentration (mg/kg).  The daily MEL intake was calculated by multiplying the daily feed intake 
(kg) with the MEL inclusion level (mg/kg).  Unlike the DEf rate that was calculated in Chapter 3 for 
meat, no assumptions were necessary for the DEf calculation in eggs, since all the parameters were 
measured. 
 
No difference in MEL DEf was found between MEL50, MEL100 and MEL500 on Day 10, although 
efficiency in MEL50 (0.686%) was slightly lower than MEL100 (0.778%) and MEL500 (0.756%). 
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4.4. Discussion 
 
4.4.1. Production parameters 
 
Since there was no difference between treatments regarding body weight on Day 1 and on Day 20, it 
can be concluded that neither MEL nor CYR had an effect on body weight and that the decrease in 
body weight that had been observed from Day 1 to Day 20, was mainly caused by high ambient 
temperatures that affected feed intake.   Similar conclusions had been made from the feed intake data, 
where feed intake declined from Day 10-20 due to high environmental temperatures.  Gao et al. 
(2010) reported no damaging effects of MEL diets containing less than 100 mg/kg on neither body 
weight nor feed intake in layer ducks.  It was interesting from the results that CYR4 had a superior 
feed intake but ultimately revealed a decreased body weight. 
 
No adverse effects were observed for egg production over time; however, there did seem to be a slight 
tendency for egg production to decrease, especially from Day 8 until Day 20, which could have been 
due to the decreased feed intake observed in all treatments during the same period.  It is postulated 
that this phenomenon may be due to the high ambient temperatures.  There was however, a significant 
difference (P < 0.01) in egg production between CYR4 and all the other treatments (Table 16). 
 
The observed increase in egg weight over time for all the treatments (Figure 8) might have been due 
to the decrease in egg production; however, it appeared as if the level of dietary MEL had some effect 
on egg weight since MEL500 had the lowest egg weight and differed significantly (P < 0.05) from all 
the other treatments except for MEL100.  Gao et al. (2010) reported no negative effects on egg weight 
after feeding diets containing MEL levels of up to 100 mg/kg to layer ducks.  From the results, it can 
be concluded that some detrimental effects in egg weight can already be observed at MEL inclusion 
levels of 100 mg/kg and that 500 mg/kg MEL had a definite adverse effect on egg weight.  
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4.4.2. Melamine concentrations in eggs 
 
In the current study, MEL was already detected in eggs within the first day, similarly to Chen et al. 
(2010) who indicated that MEL was rapidly distributed to eggs.  Bai et al. (2010) did not measure 
MEL concentrations on Day 1, but they found peak MEL levels already on Day 2.  Melamine 
concentrations peaked very soon after first ingestion and for MEL50 and MEL100, peak values were 
already observed on Day 1.  It happened that concentrations started to decrease after about a week.  In 
the broiler trial (Chapter 3), it was also noted that MEL concentrations in tissues started to decrease 
over time.  Similar observations were reported by Lü et al. (2009) in broilers and Cruywagen et al. 
(2010) in lambs, who hypothesized that the animal’s ability to clear MEL from tissues might increase 
over time.  The decrease was the most prominent in the MEL500 group and started on Day 7 while the 
decrease in MEL50 already manifested on Day 4.  There was a dose-response relationship between 
the dietary MEL inclusion levels and MEL concentrations in the eggs, which was confirmed by Bai et 
al. (2010), Chen et al. (2010) and Gao et al. (2010).  The results were proportionally much higher than 
those reported by Bai et al. (2010), Chen et al. (2010) and Gao et al. (2010) and might be due to 
different detection methods used.  Bai et al. (2010) used the high-performance liquid chromatography-
ultraviolet method and Chen et al. (2010) the gas chromatography-mass spectrometry method, 
whereas Gao et al. (2010) used the LC-MS/MS method.  From the results reported by Chen et al. 
(2010), 100 mg/kg dietary MEL did not result in egg samples containing more than 2.5 mg/kg MEL, 
which is the maximum residue level allowed in food.  In the current study, results revealed 
distribution levels of 2.24 to 4.45 mg/kg for similar dietary levels, suggesting that a diet containing 
more than 100 mg/kg MEL could violate the permitted 2.5 mg/kg inclusion level.  
 
It was evident that the MEL levels rapidly decreased after the onset of the withdrawal period and on 
Day 6 all the treatment samples contained <0.05 mg/kg MEL.  Similar results were reported (MAFF, 
2010) where undetectable levels of MEL (<0.04 mg/kg) were found in eggs within seven days after 
withdrawing diets that contained 30 mg/kg of MEL.  A model constructed by Gao et al. (2010) 
revealed that the half-life of MEL in eggs was <18 hours, emphasising the rapid excretion of MEL 
from the body.  Elevated MEL concentrations needed a longer time period to be withdrawn from eggs, 
which is in agreement with Bai et al. (2010), Chen et al. (2010) and Gao et al. (2010).  The 
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assumption has been made by Gao et al. (2010) that MEL mainly exists in a free form in the body, 
which attributed to the rapid elimination and that higher dose levels were deposited more extensively 
in other tissues which is why it may have taken longer to be eliminated.  It might also be that the 
kidneys can only manage a certain load and that excess MEL would therefore need more time to be 
cleared.  No MEL from the CYR4 treatment could be detected in any of the samples in the current 
study.   
 
4.4.3. The comparison of melamine concentrations in yolk, albumin and whole eggs 
 
The available literature gave the impression that the highest MEL concentrations detected in body 
tissues are found in tissues containing high protein levels (Anderson et al., 1987; MAFF, 2010), 
excluding the kidneys and liver which have to eliminate toxins from the body and high MEL levels in 
these organs are to be expected.  The current test results revealed that albumin contained the highest 
MEL concentration, compared to the whole egg and yolk and Yang et al. (2009) reported similar 
findings.  The albumin contains most of the protein fraction of the egg and therefore the reported 
results appeared to be in order.   
 
4.4.4. Distribution efficiency rate (DEf) 
 
The main reason for calculating the DEf rate was to express the MEL concentrations measured in eggs 
as a fraction of the ingested MEL.  The current method can be described as an alternative for reporting 
the distribution efficiency and differed from other reported methods to express efficiencies (Bai et al., 
2010; Chen et al., 2010; Gao et al., 2010; MAFF, 2010 and Yuchang et al., 2010).  In the current 
study, the method accounted for the actual amount of MEL that had been ingested per day and 
retained in the egg.  Other reports only mentioned the concentration at which MEL was deposited in 
eggs as a ratio of the concentration of MEL in the feed.  The calculation method used in the current 
trial was first reported by Cruywagen et al. (2009) for MEL distribution to milk of Holstein cows 
(2.1%), followed by a reported 3.6% in the L. dorsi of Merino sheep (Cruywagen et al., 2010).  The 
DEf of MEL to eggs was calculated on Day 10 to be 0.69% for MEL50, 0.78% for MEL100 and 
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0.76% for MEL500.  There were no differences between treatments regarding distribution.  It was 
difficult to determine the retention time of MEL in the body and, as most others, a retention time of 
seven days were assumed.  These findings might be subjected to change in the future when daily 
withdrawal depletion rates have been confirmed. 
 
4.5. Conclusion 
 
Layer hens were fed diets containing 0, 50, 100 and 500 mg/kg of MEL to determine the effect of 
MEL on production parameters and the possible distribution of MEL to eggs.  The current test results 
suggests that MEL levels up to 500 mg/kg had no marked effect on body weight; however, feed intake 
and egg weights noticeably decreased in the 500 mg/kg group.  Within 24 hours after ingestion, MEL 
could be detected in egg samples for all treatment groups receiving MEL.  A plateau was reached for 
each treatment and a definite decreasing trend was observed for all treatments from seven until ten 
days.  This would suggest that the birds developed an increased capacity over time to clear MEL from 
the body.  Even though the actual concentration levels differed from other reports, all of the results 
had similar tendencies as reported by other researchers.  The MEL distribution levels were found to be 
dose-related to the concentration of MEL included in the feed.   
 
A rapid decrease in MEL residual levels were detected after a withdrawal period had been 
implemented and within six days MEL levels were below 0.05 mg/kg.  Despite an increased feed 
intake and a decrease in egg production, no production parameters were influenced by CYR inclusion 
and no MEL could be detected in eggs due to the inclusion of 4 mg/kg dietary CYR.  Therefore, it 
could be concluded that the application of the Larvadex® 1% premix in layer feed did not result in any 
MEL distribution in eggs due to CYR metabolism.  Albumin contained the highest MEL residual 
concentration followed by the whole egg and yolk.  A MEL DEf was estimated by expressing the total 
amount of MEL deposited in eggs as a fraction of the total MEL ingested per day.  These results were 
comparable to those reported for other species (Merino L. dorsi) and products (Holstein milk). 
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CHAPTER 5                                                                            
General conclusion 
 
During the past four years, the illegal inclusion of the organic chemical, melamine (MEL), has been 
detected in infant formula, pet food and certain other food products.  Since it is known that MEL has 
no nutritional value and has been proven to be a causative agent of renal damage, MEL should not be 
present in any food product.  Even though MEL adulteration could be banned from society, 
environmental MEL could still surface in food products, including poultry meat and eggs.  Melamine 
derived from the metabolism of other compounds, such as cyromazine, also has the potential to end up 
in foods.  Cyromazine (CYR) is the active ingredient of pest control agents, such as Larvadex and 
Trigard, often included in layer hen diets to control flies.  It is thus necessary to determine the 
distribution behaviour of MEL in food products, even if only for risk assessment purposes.  
 
The current study showed that dietary MEL levels of up to 500 mg/kg did not have any detrimental 
effect on production parameters for broilers.  Apart from a decreased feed intake and lower egg 
weights observed in layer hens that received diets with 500 mg/kg of MEL, no other production 
parameters were influenced by MEL.  Melamine was distributed to breast meat within two days after 
broilers had ingested MEL tainted diets and, regarding eggs, MEL was already detectable within 24 
hours after ingestion.  As the dietary MEL concentration increased from 50 and 100 mg/kg to 500 
mg/kg, a significant increase was observed in muscle tissue and egg MEL residue concentrations.  For 
all broiler treatments, a peak MEL concentration was observed at 22 days of age, which decreased 
until slaughtering at 36 days of age.  In layer hens, a MEL distribution plateau in eggs was reached for 
each MEL treatment between Days 1 and 4, followed by a definite decrease in MEL distribution from 
Day 7 until Day 10.  These findings are indicative of a possible adaption of broilers and layers in their 
capacity to clear MEL from their system.  The kidneys contained the highest MEL residue levels, 
compared to other organ tissues, such as muscle and liver.  In eggs, the distribution of MEL was 
higher to albumin than to the yolk.   
 
After a seven day withdrawal period, no more MEL could be detected in meat samples.  In eggs, a 
rapid decrease in MEL residual levels were detected after a 10 day withdrawal period and within six 
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days MEL levels were below 0.05 mg/kg.  Furthermore, no MEL could be detected in meat and egg 
samples subjected to a diet containing 4 mg/kg CYR.  Estimated distribution efficiencies of MEL to 
meat and MEL to eggs were comparable to reports on other species (Merino L. dorsi) and products 
(Holstein milk). 
 
It was concluded that dietary MEL is absorbed by broilers and layers and rapidly distributed to 
various organs, muscle and eggs.  Upon withdrawal, MEL concentration in these tissues can be 
expected to decline to undetectable levels within seven days. 
 
Thus far, global efforts to completely clear food from MEL remain as failed attempts.  Joined forces 
between governments and all participating food manufactures will ensure safe food.  However, 
differing priorities between governments (food safety) and manufacturers (generating profit) will 
remain to ruin the perfect concept.    
 
